<html>
<head>
<META HTTP-EQUIV='Content-Type' CONTENT='text/html; charset=big5'>
<?xml version="1.0" encoding="UTF-8"?> 
<html xmlns="http://www.w3.org/1999/xhtml"
xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2017-03-09/ifrs-full"
xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
xmlns:link="http://www.xbrl.org/2003/linkbase"
xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
xmlns:xbrli="http://www.xbrl.org/2003/instance"
xmlns:xlink="http://www.w3.org/1999/xlink"
xmlns:ix="http://www.xbrl.org/2013/inlineXBRL"
xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26"
xmlns:tifrs-SCF="http://www.xbrl.org/tifrs/scf/2020-06-30"
xmlns:tifrs-ar="http://www.xbrl.org/tifrs/ar/2020-06-30"
xmlns:tifrs-bsci-ci="http://www.xbrl.org/tifrs/bsci/ci/2020-06-30"
xmlns:tifrs-es="http://www.xbrl.org/tifrs/es/2020-06-30"
xmlns:tifrs-notes="http://www.xbrl.org/tifrs/notes/2020-06-30">
<head> 
	<meta http-equiv="Content-Type" content="text/html; charset=utf-8" /> 
	<title> 6472 2023Q4 Financial report</title> 
	<script src="https://code.jquery.com/jquery-3.2.1.min.js" type="text/javascript"></script> 
	<script type="text/javascript"> 
		/*<![CDATA[*/ 
		function showChineseReport() { 
			$(".zh").show();
			$(".en").hide();
		}
		function showEnglishReport() {
			$(".en").show();
			$(".zh").hide();
		}
		$(document).ready(function() { 
			if (location.search.indexOf("?") != -1 && 
			location.search.split("?")[1].split("=")[1] == "en") 
				showEnglishReport(); 
			else 
				showChineseReport(); 
		});	
		/*]]>*/ 
	</script> 
	<style type="text/css"> 
		body,html {height: 100%;} 
		body {font-size: 15px;font-family: Arial;color: #000;background: #4E5869;margin: 0;padding: 0;background-color: #FFF;} 
		td,th {border: 1px solid #dddddd;padding: 5px;color: #333;background-color: #FFF;} 
		th#t1 {color: #165c98 !important;} 
		ul,ol,dl {padding: 0;margin: 0;} 
		h3 {color: #165c98;font-size: 18px;} 
		pre {font-size: 15px;font-family: Arial;} 
		.container {width: 100%;background: #FFF;margin: 0 auto;background-color: #999;} 
		.header {text-align: center;background: #165c98;margin-right: auto;color: #fff;} 
		.header > div:first-of-type {position: absolute;right: 15px;top: 15px;} 
		.header > div:nth-of-type(2) {font-size: 25px;text-align: center;line-height: 35px;} 
		.header a {text-decoration: none;margin:0 10px;color: #ffffff;} 
		.nav {float: left;width: 200px;height: calc(100% - 85px);overflow: auto;background: #fff;padding-bottom: 15px;} 
		.nav > div {padding: 10px;color: #165c98;font-size: 20px;font-weight: bold;} 
		.nav > ul {list-style: none;border-top: 1px solid #666;margin-bottom: 15px;} 
		.nav > ul li{border-bottom: 1px solid #666;} 
		.nav > ul a{padding: 5px 2px 5px 10px;display: block;text-decoration: none;background: #fff;color: #333;} 
		.nav > ul a:hover{background: #165c98;color: #fff;} 
		.content {width: calc(100% - 200px);height: calc(100% - 70px); float: left;background: #efefef;overflow: auto;} 
		.content > div[id*="link"] {height: 15px;} 
		.content table {border-collapse: collapse;margin: 0 20px;} 
		.content ul, 
		.content ol {padding: 15px 10px 10px 15px;} 
		.content table tr th {background: #7fcef5;color: #165c98;} 
		.content table tr:first-child th {background: #165c98;color: #fff;font-size: 15px;text-align: left;} 
		.content table tr:nth-of-type(odd) > td {background-color: #d3edfa;} 
		.title {font-size: 18px;font-weight: bold;margin-left: 20px;} 
		.rptidx {color: #000;margin-left: 20px;} 
		.amt {text-align: right} 
		.note {font-family: 細明體} 
		@media print{ 
			.header a{display: none;} 
			.nav{display: none;} 
			.content{width: 100%;height:auto;float: inherit;overflow: inherit;background: #fff!important;} 
			.content table{width: 100%!important;margin: 0;} 
			body{color: #000;} 
			td,th{color: #000;border: 1px solid #000;} 
		} 
	</style> 
</head> 
<body> 
	<div style="display:none"> 
		<ix:header> 
			<ix:hidden> 
				<ix:nonNumeric name="tifrs-notes:CompanyID" contextRef="From20230101To20231231">6472</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:CompanyChineseName" contextRef="From20230101To20231231">保瑞藥業股份有限公司</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:CompanyEnglishName" contextRef="From20230101To20231231">BORA PHARMACEUTICALS CO., LTD</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:Year" contextRef="From20230101To20231231">2023</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:Quarter" contextRef="From20230101To20231231">4</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:ReportType" contextRef="From20230101To20231231">Financial report (general)</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:ReportCategory" contextRef="From20230101To20231231">Consolidated report</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:Market" contextRef="From20230101To20231231">Listed company</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:IndustrySector" contextRef="From20230101To20231231">Commercial and industrial</ix:nonNumeric> 
			</ix:hidden> 
			<ix:references>
				<link:schemaRef xlink:href="tifrs-ci-cr-2020-06-30.xsd" xlink:type="simple"/>
			</ix:references>
			<ix:resources> 
				<xbrli:context id="AsOf20221231_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20240307"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2024-03-07</xbrli:instant> 
					</xbrli:period> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6472</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:unit id="TWD"> 
					<xbrli:measure>iso4217:TWD</xbrli:measure> 
				</xbrli:unit> 
				<xbrli:unit id="Shares"> 
					<xbrli:measure>xbrli:shares</xbrli:measure> 
				</xbrli:unit> 
				<xbrli:unit id="EarningsPerShare"> 
					<xbrli:divide> 
						<xbrli:unitNumerator> 
							<xbrli:measure>iso4217:TWD</xbrli:measure> 
						</xbrli:unitNumerator> 
						<xbrli:unitDenominator> 
							<xbrli:measure>xbrli:shares</xbrli:measure> 
						</xbrli:unitDenominator> 
					</xbrli:divide> 
				</xbrli:unit> 
				<xbrli:unit id="Pure"> 
					<xbrli:measure>xbrli:pure</xbrli:measure> 
				</xbrli:unit> 
			</ix:resources> 
		</ix:header> 
	</div> 
	<div class="container"> 
		<div class="header"> 
			<div> 
				<a href="javascript:showChineseReport();">中文</a>|<a href="javascript:showEnglishReport();">English</a> 
			</div> 
			<div> 
				<span class="zh">6472 保瑞藥業股份有限公司<br />2023年第4季合併財務報告</span> 
				<span class="en">6472 BORA PHARMACEUTICALS CO., LTD<br />2023Q4 Consolidated Financial Report</span> 
			</div> 
		</div> 
		<div class="nav"> 
			<div>
				<span class="zh">財務報表索引</span>
				<span class="en">Report Index</span>
			</div> 
			<ul> 
				<li>
					<a href="#BalanceSheet">
						<span class="zh">資產負債表</span>
						<span class="en">Balance Sheet</span>
					</a>
				</li>
				<li>
					<a href="#StatementOfComprehensiveIncome">
						<span class="zh">綜合損益表</span>
						<span class="en">Statement of Comprehensive Income</span>
					</a>
				</li> 
				<li>
					<a href="#StatementsOfCashFlows">
						<span class="zh">現金流量表</span>
						<span class="en">Statements of Cash Flows</span>
					</a>
				</li> 
				<li>
					<a href="#StatementsOfChangeInEquity">
						<span class="zh">權益變動表</span> 
						<span class="en">Statements of Change in Equity</span>
					</a>
				</li>
				<span class="zh">
	    			<li><a href="#ReportOfIndependentAuditors">會計師查核（核閱）報告</a></li>
	    		</span>
	    		<span class="en">
	    			<li><a href="#ReportOfIndependentAuditorsEN">Independent Auditors' (Review) Report</a></li>
	    		</span>
				<span class="zh">
	    			<li><a style="background-color:#ceceef;">財務報表附註</a></li>
	    			<li><a href="#HistoryAndOrganization">公司沿革及業務範圍</a></li>
	    			<li><a href="#DateAndProceduresOfAuthorisationForIssueOfFinancialStatements">通過財報之日期及程序</a></li>
	    			<li><a href="#ApplicationOfNewlyIssuedOrAmendedStandardsAndInterpretations">新發布及修訂準則及解釋之適用</a></li>
	    			<li><a href="#SummaryOfSignificantAccountingPolicies">重大會計政策之彙總說明</a></li>
	    			<li><a href="#SourcesOfUncertaintyFromSignificantAccountingJudgmentsAssumptionsAndEstimations">會計重大判斷、假設及估計不確性之主要來源</a></li>
	    			<li><a style="background-color:#ceceef;">其它財報附註</a></li>
	    			<li><a href="#TradeAndOtherReceivables">應收款項</a></li>
	    			<li><a href="#TransactionsBetweenRelatedParties">關係人交易</a></li>
	    			<li><a href="#LoansToOthers">資金貸與他人</a></li>
	    			<li><a href="#EndorsementGuaranteeProvidedToOthers">為他人背書保證</a></li>
	    			<li><a href="#SignificantIntercompanyTransactionsBetweenConsolidatedEntities">母子公司間業務關係及重要交易往來情形</a></li>
	    			<li><a href="#NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">被投資公司名稱、所在地區…等相關資訊</a></li>
	    			<li><a href="#InvestmentInMainlandChina">大陸地區投資</a></li>
	    			<li><a href="#NonoperatingIncomeAndExpenses">營業外收入及支出</a></li>
				</span>
			</ul> 
		</div> 
		<div class="content"> 
			<!-- 資產負債表 -->
			<div id="BalanceSheet"></div> 
			<div class="rptidx"><span class="zh">單位：新臺幣仟元</span><span class="en">Unit: NT$ thousands</span></div> 
				<table style="width:90%"> 
					<tr><th colspan="4"><span class="zh">資產負債表</span><span class="en">Balance Sheet</span></th></tr> 
					<tr> 
						<th><span class="zh">代號</span><span class="en">Code</span></th> 
						<th><span class="zh">會計項目</span><span class="en">Accounting Title</span></th> 
						<th><span class="zh">2023年12月31日</span><span class="en">2023/12/31</span></th> 
						<th><span class="zh">2022年12月31日</span><span class="en">2022/12/31</span></th> 
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">資產</span><span class="en">Assets</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　流動資產</span><span class="en">　Current assets</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1100</td> 
						<td><span class="zh">　　現金及約當現金</span><span class="en">　　Cash and cash equivalents</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,053,294</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,281,319</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1110</td> 
						<td><span class="zh">　　透過損益按公允價值衡量之金融資產－流動</span><span class="en">　　Current financial assets at fair value through profit or loss</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentFinancialAssetsAtFairValueThroughProfitOrLoss" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">14</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1136</td> 
						<td><span class="zh">　　按攤銷後成本衡量之金融資產－流動</span><span class="en">　　Current financial assets at amortised cost</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentFinancialAssetsAtAmortisedCost" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">342,627</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentFinancialAssetsAtAmortisedCost" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">247,617</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1140</td> 
						<td><span class="zh">　　合約資產－流動</span><span class="en">　　Current contract assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentContractAssets" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">15,111</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentContractAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">35,197</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1150</td> 
						<td><span class="zh">　　應收票據淨額</span><span class="en">　　Notes receivable, net</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NotesReceivableNet" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">54,323</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NotesReceivableNet" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">36,900</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1170</td> 
						<td><span class="zh">　　應收帳款淨額</span><span class="en">　　Accounts receivable, net</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:AccountsReceivableNet" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,890,584</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:AccountsReceivableNet" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,028,343</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1180</td> 
						<td><span class="zh">　　應收帳款－關係人淨額</span><span class="en">　　Accounts receivable due from related parties, net</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:AccountsReceivableDuefromRelatedPartiesNet" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">68,290</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:AccountsReceivableDuefromRelatedPartiesNet" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">19,707</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1200</td> 
						<td><span class="zh">　　其他應收款</span><span class="en">　　Other receivables</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentReceivables" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">82,614</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentReceivables" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">286,376</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">130X</td> 
						<td><span class="zh">　　存貨</span><span class="en">　　Current inventories</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Inventories" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,156,134</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Inventories" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,946,818</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1410</td> 
						<td><span class="zh">　　預付款項</span><span class="en">　　Prepayments</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentPrepayments" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">801,425</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentPrepayments" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">291,419</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1470</td> 
						<td><span class="zh">　　其他流動資產</span><span class="en">　　Other current assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentAssets" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">138,626</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">67,096</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1479</td> 
						<td><span class="zh">　　　其他流動資產－其他</span><span class="en">　　　Other current assets, others</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OtherCurrentAssetsOthers" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">138,626</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OtherCurrentAssetsOthers" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">67,096</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">11XX</td> 
						<td><span class="zh">　　流動資產合計</span><span class="en">　　Total current assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">10,603,028</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,240,806</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　非流動資產</span><span class="en">　Non-current assets</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1510</td> 
						<td><span class="zh">　　透過損益按公允價值衡量之金融資產－非流動</span><span class="en">　　Non-current financial assets at fair value through profit or loss</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,336</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1517</td> 
						<td><span class="zh">　　透過其他綜合損益按公允價值衡量之金融資產－非流動</span><span class="en">　　Non-current financial assets at fair value through other comprehensive income</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,758</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1535</td> 
						<td><span class="zh">　　按攤銷後成本衡量之金融資產－非流動</span><span class="en">　　Non-current financial assets at amortised cost</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentFinancialAssetsAtAmortisedCost" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">13,500</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentFinancialAssetsAtAmortisedCost" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">62,027</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1600</td> 
						<td><span class="zh">　　不動產、廠房及設備</span><span class="en">　　Property, plant and equipment</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,649,994</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,645,112</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1755</td> 
						<td><span class="zh">　　使用權資產</span><span class="en">　　Right-of-use assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">842,586</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">655,196</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1760</td> 
						<td><span class="zh">　　投資性不動產淨額</span><span class="en">　　Investment property, net</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:InvestmentProperty" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">17,018</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:InvestmentProperty" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">17,626</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1780</td> 
						<td><span class="zh">　　無形資產</span><span class="en">　　Intangible assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,595,670</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,147,431</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1840</td> 
						<td><span class="zh">　　遞延所得稅資產</span><span class="en">　　Deferred tax assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:DeferredTaxAssets" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,044,615</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:DeferredTaxAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">829,636</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1900</td> 
						<td><span class="zh">　　其他非流動資產</span><span class="en">　　Other non-current assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherNoncurrentAssets" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">277,836</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherNoncurrentAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">161,045</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1915</td> 
						<td><span class="zh">　　　預付設備款</span><span class="en">　　　Prepayments for business facilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:PrepaymentsForBusinessFacilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">149,991</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:PrepaymentsForBusinessFacilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">37,803</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1920</td> 
						<td><span class="zh">　　　存出保證金</span><span class="en">　　　Guarantee deposits paid</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:GuaranteeDepositsPaid" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">44,111</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:GuaranteeDepositsPaid" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">38,298</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1990</td> 
						<td><span class="zh">　　　其他非流動資產－其他</span><span class="en">　　　Other non-current assets, others</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OtherNoncurrentAssetsOthers" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">83,734</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OtherNoncurrentAssetsOthers" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">84,944</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">15XX</td> 
						<td><span class="zh">　　非流動資產合計</span><span class="en">　　Total non-current assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">14,448,977</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">10,520,409</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1XXX</td> 
						<td><span class="zh">　資產總計</span><span class="en">　Total assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">25,052,005</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">22,761,215</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">負債及權益</span><span class="en">Liabilities and equity</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　負債</span><span class="en">　Liabilities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　流動負債</span><span class="en">　　Current liabilities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2100</td> 
						<td><span class="zh">　　　短期借款</span><span class="en">　　　Current borrowings</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ShorttermBorrowings" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">767,508</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ShorttermBorrowings" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,161,065</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2120</td> 
						<td><span class="zh">　　　透過損益按公允價值衡量之金融負債－流動</span><span class="en">　　　Current financial liabilities at fair value through profit or loss</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,584,841</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">695,476</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2130</td> 
						<td><span class="zh">　　　合約負債－流動</span><span class="en">　　　Current contract liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentContractLiabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">224,597</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentContractLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">85,692</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2150</td> 
						<td><span class="zh">　　　應付票據</span><span class="en">　　　Notes payable</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NotesPayable" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">18,845</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NotesPayable" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,856</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2170</td> 
						<td><span class="zh">　　　應付帳款</span><span class="en">　　　Accounts payable</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">361,605</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">426,851</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2180</td> 
						<td><span class="zh">　　　應付帳款－關係人</span><span class="en">　　　Accounts payable to related parties</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">25,031</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2200</td> 
						<td><span class="zh">　　　其他應付款</span><span class="en">　　　Other payables</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentPayables" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,526,752</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentPayables" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,891,975</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2220</td> 
						<td><span class="zh">　　　其他應付款項－關係人</span><span class="en">　　　Other payables to related parties</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OtherPayablesToRelatedParties" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OtherPayablesToRelatedParties" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,129</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2230</td> 
						<td><span class="zh">　　　本期所得稅負債</span><span class="en">　　　Current tax liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentTaxLiabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">987,430</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentTaxLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">238,651</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2250</td> 
						<td><span class="zh">　　　負債準備－流動</span><span class="en">　　　Current provisions</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentProvisions" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">144,523</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentProvisions" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">134,381</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2280</td> 
						<td><span class="zh">　　　租賃負債－流動</span><span class="en">　　　Current lease liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:CurrentLeaseLiabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">106,039</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:CurrentLeaseLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">75,307</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2300</td> 
						<td><span class="zh">　　　其他流動負債</span><span class="en">　　　Other current liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentLiabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,506,921</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,757,109</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2320</td> 
						<td><span class="zh">　　　　一年或一營業週期內到期長期負債</span><span class="en">　　　　Long-term liabilities, current portion</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:LongtermLiabilitiesCurrentPortion" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">630,502</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:LongtermLiabilitiesCurrentPortion" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">725,627</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2322</td> 
						<td><span class="zh">　　　　　一年或一營業週期內到期長期借款</span><span class="en">　　　　　Long-term borrowings, current portion</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentPortionOfLongtermBorrowings" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">630,502</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentPortionOfLongtermBorrowings" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">725,627</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2365</td> 
						<td><span class="zh">　　　　退款負債－流動</span><span class="en">　　　　Current refund liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:CurrentRefundLiabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,866,901</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:CurrentRefundLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,023,565</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2399</td> 
						<td><span class="zh">　　　　其他流動負債－其他</span><span class="en">　　　　Other current liabilities, others</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OtherCurrentLiabilitiesOthers" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,518</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OtherCurrentLiabilitiesOthers" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,917</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">21XX</td> 
						<td><span class="zh">　　　流動負債合計</span><span class="en">　　　Total current liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,229,061</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">10,495,523</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　非流動負債</span><span class="en">　　Non-current liabilities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2500</td> 
						<td><span class="zh">　　　透過損益按公允價值衡量之金融負債－非流動</span><span class="en">　　　Non-current financial liabilities at fair value through profit or loss</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">359,604</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">928,206</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2527</td> 
						<td><span class="zh">　　　合約負債－非流動</span><span class="en">　　　Non-current contract liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentContractLiabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentContractLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,184</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2530</td> 
						<td><span class="zh">　　　應付公司債</span><span class="en">　　　Bonds payable</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentPortionOfNoncurrentBondsIssued" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,538,361</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentPortionOfNoncurrentBondsIssued" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">642,363</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2540</td> 
						<td><span class="zh">　　　長期借款</span><span class="en">　　　Non-current portion of non-current borrowings</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:LongtermBorrowings" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,185,260</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:LongtermBorrowings" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,394,474</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2550</td> 
						<td><span class="zh">　　　負債準備－非流動</span><span class="en">　　　Non-current provisions</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentProvisions" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">216,805</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentProvisions" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">341,716</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2570</td> 
						<td><span class="zh">　　　遞延所得稅負債</span><span class="en">　　　Deferred tax liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:DeferredTaxLiabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">701,736</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:DeferredTaxLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">742,848</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2580</td> 
						<td><span class="zh">　　　租賃負債－非流動</span><span class="en">　　　Non-current lease liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentFinanceLeaseLiabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">763,333</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentFinanceLeaseLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">596,879</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2600</td> 
						<td><span class="zh">　　　其他非流動負債</span><span class="en">　　　Other non-current liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherNoncurrentLiabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">292,034</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherNoncurrentLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">474,566</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2670</td> 
						<td><span class="zh">　　　　其他非流動負債－其他</span><span class="en">　　　　Other non-current liabilities, others</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OtherNoncurrentLiabilitiesOthers" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">292,034</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OtherNoncurrentLiabilitiesOthers" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">474,566</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">25XX</td> 
						<td><span class="zh">　　　非流動負債合計</span><span class="en">　　　Total non-current liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,057,133</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,125,236</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2XXX</td> 
						<td><span class="zh">　　負債總計</span><span class="en">　　Total liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Liabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">13,286,194</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Liabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">17,620,759</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　權益</span><span class="en">　Equity</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　歸屬於母公司業主之權益</span><span class="en">　　Equity attributable to owners of parent</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　　股本</span><span class="en">　　　Share capital</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3110</td> 
						<td><span class="zh">　　　　普通股股本</span><span class="en">　　　　Ordinary share</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OrdinaryShare" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,014,128</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OrdinaryShare" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">753,815</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3140</td> 
						<td><span class="zh">　　　　預收股本</span><span class="en">　　　　Advance receipts for share capital</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:AdvanceReceiptsForShareCapital" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">853</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:AdvanceReceiptsForShareCapital" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,107</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3100</td> 
						<td><span class="zh">　　　　股本合計</span><span class="en">　　　　Total Share Capital</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,014,981</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">756,922</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　　資本公積</span><span class="en">　　　Capital surplus</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3200</td> 
						<td><span class="zh">　　　　資本公積合計</span><span class="en">　　　　Total capital surplus</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CapitalReserve" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,318,350</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CapitalReserve" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,236,380</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　　保留盈餘</span><span class="en">　　　Retained earnings</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3310</td> 
						<td><span class="zh">　　　　法定盈餘公積</span><span class="en">　　　　Legal reserve</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:StatutoryReserve" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">355,501</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:StatutoryReserve" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">216,436</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3320</td> 
						<td><span class="zh">　　　　特別盈餘公積</span><span class="en">　　　　Special reserve</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:SpecialReserve" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:SpecialReserve" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,919</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3350</td> 
						<td><span class="zh">　　　　未分配盈餘（或待彌補虧損）</span><span class="en">　　　　Unappropriated retained earnings (accumulated deficit)</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:UnappropriatedRetainedEarningsAaccumulatedDeficit" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,373,116</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:UnappropriatedRetainedEarningsAaccumulatedDeficit" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,308,664</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3300</td> 
						<td><span class="zh">　　　　保留盈餘合計</span><span class="en">　　　　Total retained earnings</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:RetainedEarnings" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,728,617</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:RetainedEarnings" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,549,019</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　　其他權益</span><span class="en">　　　Other equity interest</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3400</td> 
						<td><span class="zh">　　　　其他權益合計</span><span class="en">　　　　Total other equity interest</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherEquityInterest" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">73,807</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherEquityInterest" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">39,093</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3500</td> 
						<td><span class="zh">　　　庫藏股票</span><span class="en">　　　Treasury shares</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:TreasuryShares" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">50,968</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:TreasuryShares" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">53,092</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">31XX</td> 
						<td><span class="zh">　　　歸屬於母公司業主之權益合計</span><span class="en">　　　Total equity attributable to owners of parent</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:EquityAttributableToOwnersOfParent" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,084,787</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:EquityAttributableToOwnersOfParent" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,528,322</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">36XX</td> 
						<td><span class="zh">　　非控制權益</span><span class="en">　　Non-controlling interests</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncontrollingInterests" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,681,024</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncontrollingInterests" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">612,134</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3XXX</td> 
						<td><span class="zh">　　權益總額</span><span class="en">　　Total equity</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">11,765,811</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,140,456</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3X2X</td> 
						<td><span class="zh">　負債及權益總計</span><span class="en">　Total liabilities and equity</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">25,052,005</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">22,761,215</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3998</td> 
						<td><span class="zh">　預收股款（權益項下）之約當發行股數</span><span class="en">　Equivalent issue shares of advance receipts for ordinary share</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">85,320</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">310,664</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3999</td> 
						<td><span class="zh">　母公司暨子公司所持有之母公司庫藏股股數（單位：股）</span><span class="en">　Number of shares in entity held by entity and by its subsidiaries</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">288,000</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">300,000</ix:nonFraction> </pre></td>
					</tr> 
				</table> 
				<br /> 
			<!-- 綜合損益表 -->
			<div id="StatementOfComprehensiveIncome"></div> 
			<div class="rptidx"><span class="zh">單位：新臺幣仟元　每股盈餘單位：新台幣元</span><span class="en">Unit: NT$ thousands　EPS Unit: NT$</span></div> 
				<table style="width:90%"> 
					<tr><th colspan="4"><span class="zh">綜合損益表</span><span class="en">Statement of Comprehensive Income</span></th></tr> 
					<tr> 
						<th><span class="zh">代號</span><span class="en">Code</span></th> 
						<th><span class="zh">會計項目</span><span class="en">Accounting Title</span></th> 
						<th><span class="zh">2023年1月1日至12月31日</span><span class="en">2023/1/1To12/31</span></th> 
						<th><span class="zh">2022年1月1日至12月31日</span><span class="en">2022/1/1To12/31</span></th> 
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">營業收入</span><span class="en">Operating revenue</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">4000</td> 
						<td><span class="zh">　營業收入合計</span><span class="en">　Total operating revenue</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Revenue" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">14,200,068</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Revenue" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">10,494,470</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">營業成本</span><span class="en">Operating costs</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">5000</td> 
						<td><span class="zh">　營業成本合計</span><span class="en">　Total operating costs</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OperatingCosts" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,208,830</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OperatingCosts" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,581,695</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">5900</td> 
						<td><span class="zh">營業毛利（毛損）</span><span class="en">Gross profit (loss) from operations</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:GrossProfitLossFromOperations" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,991,238</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:GrossProfitLossFromOperations" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,912,775</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">5950</td> 
						<td><span class="zh">營業毛利（毛損）淨額</span><span class="en">Gross profit (loss) from operations</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,991,238</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,912,775</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">營業費用</span><span class="en">Operating expenses</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">6100</td> 
						<td><span class="zh">　推銷費用</span><span class="en">　Selling expenses</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:SellingExpense" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">447,093</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:SellingExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">260,115</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">6200</td> 
						<td><span class="zh">　管理費用</span><span class="en">　Administrative expenses</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdministrativeExpense" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">996,846</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdministrativeExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">601,406</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">6300</td> 
						<td><span class="zh">　研究發展費用</span><span class="en">　Research and development expenses</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">298,160</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">129,078</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">6000</td> 
						<td><span class="zh">　營業費用合計</span><span class="en">　Total operating expenses</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OperatingExpense" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,742,099</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OperatingExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">990,599</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">6900</td> 
						<td><span class="zh">營業利益（損失）</span><span class="en">Net operating income (loss)</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,249,139</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,922,176</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">營業外收入及支出</span><span class="en">Non-operating income and expenses</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　其他收入</span><span class="en">　Other income</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7010</td> 
						<td><span class="zh">　　其他收入合計</span><span class="en">　　Total other income</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">93,392</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">30,684</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　其他利益及損失</span><span class="en">　Other gains and losses</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7020</td> 
						<td><span class="zh">　　其他利益及損失淨額</span><span class="en">　　Other gains and losses, net</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherGainsLosses" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,107,146</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherGainsLosses" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,132</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　財務成本</span><span class="en">　Finance costs</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7050</td> 
						<td><span class="zh">　　財務成本淨額</span><span class="en">　　Finance costs, net</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">171,239</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">108,727</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7000</td> 
						<td><span class="zh">　營業外收入及支出合計</span><span class="en">　Total non-operating income and expenses</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-bsci-ci:NonoperatingIncomeAndExpenses" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,184,993</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-bsci-ci:NonoperatingIncomeAndExpenses" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">82,175</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7900</td> 
						<td><span class="zh">繼續營業單位稅前淨利（淨損）</span><span class="en">Profit (loss) from continuing operations before tax</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,064,146</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,840,001</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">所得稅費用（利益）</span><span class="en">Tax expense (income)</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7950</td> 
						<td><span class="zh">　所得稅費用（利益）合計</span><span class="en">　Total tax expense (income)</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">992,225</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">438,476</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8000</td> 
						<td><span class="zh">繼續營業單位本期淨利（淨損）</span><span class="en">Profit (loss) from continuing operations</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossFromContinuingOperations" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,071,921</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossFromContinuingOperations" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,401,525</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8200</td> 
						<td><span class="zh">本期淨利（淨損）</span><span class="en">Profit (loss)</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,071,921</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,401,525</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">其他綜合損益(淨額)</span><span class="en">Other comprehensive income</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　不重分類至損益之項目</span><span class="en">　Components of other comprehensive income that will not be reclassified to profit or loss</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8311</td> 
						<td><span class="zh">　　確定福利計畫之再衡量數</span><span class="en">　　Gains (losses) on remeasurements of defined benefit plans</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">8,681</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,399</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8349</td> 
						<td><span class="zh">　　與不重分類之項目相關之所得稅</span><span class="en">　　Income tax related to components of other comprehensive income that will not be reclassified to profit or loss</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">2,489</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,430</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8310</td> 
						<td><span class="zh">　　不重分類至損益之項目總額</span><span class="en">　　Components of other comprehensive income that will not be reclassified to profit or loss</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">6,192</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,969</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　後續可能重分類至損益之項目</span><span class="en">　Components of other comprehensive income that will be reclassified to profit or loss</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8361</td> 
						<td><span class="zh">　　國外營運機構財務報表換算之兌換差額</span><span class="en">　　Exchange differences on translation</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">50,758</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">73,805</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8399</td> 
						<td><span class="zh">　　與可能重分類之項目相關之所得稅</span><span class="en">　　Income tax related to components of other comprehensive income that will be reclassified to profit or loss</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">10,287</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">14,761</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8360</td> 
						<td><span class="zh">　　後續可能重分類至損益之項目總額</span><span class="en">　　Components of other comprehensive income that will be reclassified to profit or loss</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">40,471</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">59,044</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8300</td> 
						<td><span class="zh">　其他綜合損益（淨額）</span><span class="en">　Total other comprehensive income</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">34,279</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">63,013</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8500</td> 
						<td><span class="zh">本期綜合損益總額</span><span class="en">Total comprehensive income</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,106,200</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,464,538</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">淨利（損）歸屬於：</span><span class="en">Profit (loss), attributable to:</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8610</td> 
						<td><span class="zh">　母公司業主（淨利／損）</span><span class="en">　Profit (loss), attributable to owners of parent</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,030,142</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,391,916</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8620</td> 
						<td><span class="zh">　非控制權益（淨利／損）</span><span class="en">　Profit (loss), attributable to non-controlling interests</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">41,779</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,609</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">綜合損益總額歸屬於：</span><span class="en">Comprehensive income attributable to:</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8710</td> 
						<td><span class="zh">　母公司業主（綜合損益）</span><span class="en">　Comprehensive income, attributable to owners of parent</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,064,856</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,454,929</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8720</td> 
						<td><span class="zh">　非控制權益（綜合損益）</span><span class="en">　Comprehensive income, attributable to non-controlling interests</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">41,344</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,609</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">基本每股盈餘</span><span class="en">Basic earnings per share</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">9750</td> 
						<td><span class="zh">　基本每股盈餘合計</span><span class="en">　Total basic earnings per share</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="0" decimals="2" unitRef="EarningsPerShare">30.20</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="0" decimals="2" unitRef="EarningsPerShare">14.26</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">稀釋每股盈餘</span><span class="en">Diluted earnings per share</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">9850</td> 
						<td><span class="zh">　稀釋每股盈餘合計</span><span class="en">　Total diluted earnings per share</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="0" decimals="2" unitRef="EarningsPerShare">29.39</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="0" decimals="2" unitRef="EarningsPerShare">14.13</ix:nonFraction> </pre></td>
					</tr> 
				</table> 
				<br /> 
			<!-- 現金流量表 -->
			<div id="StatementsOfCashFlows"></div> 
			<div class="rptidx"><span class="zh">單位：新臺幣仟元</span><span class="en">Unit: NT$ thousands</span></div> 
				<table style="width:90%"> 
					<tr><th colspan="4"><span class="zh">現金流量表</span><span class="en">Statements of Cash Flows</span></th></tr> 
					<tr> 
						<th><span class="zh">代號</span><span class="en">Code</span></th> 
						<th><span class="zh">會計項目</span><span class="en">Accounting Title</span></th> 
						<th><span class="zh">2023年1月1日至12月31日</span><span class="en">2023/1/1To12/31</span></th> 
						<th><span class="zh">2022年1月1日至12月31日</span><span class="en">2022/1/1To12/31</span></th> 
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">營業活動之現金流量－間接法</span><span class="en">Cash flows from (used in) operating activities, indirect method</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A00010</td> 
						<td><span class="zh">　繼續營業單位稅前淨利（淨損）</span><span class="en">　Profit (loss) from continuing operations before tax</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,064,146</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,840,001</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A10000</td> 
						<td><span class="zh">　本期稅前淨利（淨損）</span><span class="en">　Profit (loss) before tax</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ProfitLossBeforeTax" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,064,146</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ProfitLossBeforeTax" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,840,001</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　調整項目</span><span class="en">　Adjustments</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　收益費損項目</span><span class="en">　　Adjustments to reconcile profit (loss)</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20100</td> 
						<td><span class="zh">　　　折舊費用</span><span class="en">　　　Depreciation expense</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForDepreciationExpense" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">420,088</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForDepreciationExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">258,774</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20200</td> 
						<td><span class="zh">　　　攤銷費用</span><span class="en">　　　Amortization expense</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForAmortisationExpense" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">186,198</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForAmortisationExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">66,412</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20400</td> 
						<td><span class="zh">　　　透過損益按公允價值衡量金融資產及負債之淨損失（利益）</span><span class="en">　　　Net loss (gain) on financial assets or liabilities at fair value through profit or loss</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:NetLossGainOnFinancialAssetsOrLiabilitiesAtFairValueThroughProfitOrLoss" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,044,183</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:NetLossGainOnFinancialAssetsOrLiabilitiesAtFairValueThroughProfitOrLoss" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">47,787</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20900</td> 
						<td><span class="zh">　　　利息費用</span><span class="en">　　　Interest expense</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForInterestExpense" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">171,239</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForInterestExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">108,727</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A21200</td> 
						<td><span class="zh">　　　利息收入</span><span class="en">　　　Interest income</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:AdjustmentsForInterestIncome" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">62,954</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:AdjustmentsForInterestIncome" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">11,364</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A21900</td> 
						<td><span class="zh">　　　股份基礎給付酬勞成本</span><span class="en">　　　Share-based payments</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">102,813</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">31,826</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A22500</td> 
						<td><span class="zh">　　　處分及報廢不動產、廠房及設備損失（利益）</span><span class="en">　　　Loss (gain) on disposal of property, plan and equipment</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,997</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,357</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A22900</td> 
						<td><span class="zh">　　　處分其他資產損失（利益）</span><span class="en">　　　Loss (gain) on disposal of other assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:LossGainOnDisposalOfOtherAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:LossGainOnDisposalOfOtherAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,023</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A29900</td> 
						<td><span class="zh">　　　其他項目</span><span class="en">　　　Other adjustments to reconcile profit (loss)</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherAdjustmentsToReconcileProfitLoss" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,398</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherAdjustmentsToReconcileProfitLoss" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">16,607</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20010</td> 
						<td><span class="zh">　　　收益費損項目合計</span><span class="en">　　　Total adjustments to reconcile profit (loss)</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:AdjustmentsToReconcileProfitLoss" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,874,962</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:AdjustmentsToReconcileProfitLoss" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">522,149</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　與營業活動相關之資產／負債變動數</span><span class="en">　　Changes in operating assets and liabilities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　　與營業活動相關之資產之淨變動</span><span class="en">　　　Changes in operating assets</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31125</td> 
						<td><span class="zh">　　　　合約資產（增加）減少</span><span class="en">　　　　Decrease (increase) in contract assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInContractAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">20,086</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInContractAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">35,197</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31130</td> 
						<td><span class="zh">　　　　應收票據（增加）減少</span><span class="en">　　　　Decrease (increase) in notes receivable</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInNotesReceivable" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">17,423</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInNotesReceivable" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">12,575</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31140</td> 
						<td><span class="zh">　　　　應收票據－關係人（增加）減少</span><span class="en">　　　　Decrease (increase) in notes receivable due from related parties</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInNotesReceivableDueFromRelatedParties" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInNotesReceivableDueFromRelatedParties" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,233</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31150</td> 
						<td><span class="zh">　　　　應收帳款（增加）減少</span><span class="en">　　　　Decrease (increase) in accounts receivable</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInAccountsReceivable" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,138,609</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInAccountsReceivable" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,469,620</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31160</td> 
						<td><span class="zh">　　　　應收帳款－關係人（增加）減少</span><span class="en">　　　　Decrease (increase) in accounts receivable due from related parties</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInAccountsReceivableDueFromRelatedParties" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,419</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInAccountsReceivableDueFromRelatedParties" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,002</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31180</td> 
						<td><span class="zh">　　　　其他應收款（增加）減少</span><span class="en">　　　　Decrease (increase) in other receivable</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInOtherReceivables" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,045</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInOtherReceivables" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">37,655</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31200</td> 
						<td><span class="zh">　　　　存貨（增加）減少</span><span class="en">　　　　Adjustments for decrease (increase) in inventories</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">124,499</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">99,389</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31230</td> 
						<td><span class="zh">　　　　預付款項（增加）減少</span><span class="en">　　　　Decrease (increase) in prepayments</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInPrepayments" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">9,210</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInPrepayments" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">106,166</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31240</td> 
						<td><span class="zh">　　　　其他流動資產（增加）減少</span><span class="en">　　　　Adjustments for decrease (increase) in other current assets</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">71,203</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">35,302</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31000</td> 
						<td><span class="zh">　　　　與營業活動相關之資產之淨變動合計</span><span class="en">　　　　Total changes in operating assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ChangesInOperatingAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,942,986</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:ChangesInOperatingAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,598,895</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　　與營業活動相關之負債之淨變動</span><span class="en">　　　Changes in operating liabilities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32125</td> 
						<td><span class="zh">　　　　合約負債增加（減少）</span><span class="en">　　　　Increase (decrease) in contract liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInContractLiabilities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">134,721</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInContractLiabilities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">11,774</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32130</td> 
						<td><span class="zh">　　　　應付票據增加（減少）</span><span class="en">　　　　Increase (decrease) in notes payable</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInNotesPayable" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,852</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInNotesPayable" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,057</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32140</td> 
						<td><span class="zh">　　　　應付票據－關係人增加（減少）</span><span class="en">　　　　Increase (decrease) in notes payable to related parties</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInNotesPayableToRelatedParties" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInNotesPayableToRelatedParties" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">7,596</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32150</td> 
						<td><span class="zh">　　　　應付帳款增加（減少）</span><span class="en">　　　　Increase (decrease) in accounts payable</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInAccountsPayable" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">65,844</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInAccountsPayable" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">94,802</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32160</td> 
						<td><span class="zh">　　　　應付帳款－關係人增加（減少）</span><span class="en">　　　　Increase (decrease) in accounts payable to related parties</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInAccountsPayableToRelatedParties" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">25,031</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInAccountsPayableToRelatedParties" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,366</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32180</td> 
						<td><span class="zh">　　　　其他應付款增加（減少）</span><span class="en">　　　　Increase (decrease) in other payable</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInOtherPayables" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">2,185,681</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInOtherPayables" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,447,498</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32200</td> 
						<td><span class="zh">　　　　負債準備增加（減少）</span><span class="en">　　　　Increase (decrease) in provisions</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInProvisions" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">139,197</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInProvisions" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">103,532</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32230</td> 
						<td><span class="zh">　　　　其他流動負債增加（減少）</span><span class="en">　　　　Adjustments for increase (decrease) in other current liabilities</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">155,741</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">169,382</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32000</td> 
						<td><span class="zh">　　　　與營業活動相關之負債之淨變動合計</span><span class="en">　　　　Total changes in operating liabilities</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:ChangesInOperatingLiabilities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">2,434,921</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ChangesInOperatingLiabilities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,603,203</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A30000</td> 
						<td><span class="zh">　　　與營業活動相關之資產及負債之淨變動合計</span><span class="en">　　　Total changes in operating assets and liabilities</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:ChangesInOperatingAssetsAndLiabilities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">491,935</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ChangesInOperatingAssetsAndLiabilities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,308</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20000</td> 
						<td><span class="zh">　　調整項目合計</span><span class="en">　　Total adjustments</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:Adjustments" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,383,027</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:Adjustments" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">526,457</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A33000</td> 
						<td><span class="zh">　營運產生之現金流入（流出）</span><span class="en">　Cash inflow (outflow) generated from operations</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperations" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,447,173</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperations" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,366,458</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A33100</td> 
						<td><span class="zh">　收取之利息</span><span class="en">　Interest received</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:InterestReceivedClassifiedAsOperatingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">62,954</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:InterestReceivedClassifiedAsOperatingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">11,364</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A33500</td> 
						<td><span class="zh">　退還（支付）之所得稅</span><span class="en">　Income taxes refund (paid)</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">896,470</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">367,748</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">AAAA</td> 
						<td><span class="zh">營業活動之淨現金流入（流出）</span><span class="en">Net cash flows from (used in) operating activities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,613,657</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,010,074</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">投資活動之現金流量</span><span class="en">Cash flows from (used in) investing activities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B00040</td> 
						<td><span class="zh">　取得按攤銷後成本衡量之金融資產</span><span class="en">　Acquisition of financial assets at amortised cost</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:AcquisitionOfFinancialAssetsAtAmortisedCost" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">53,648</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:AcquisitionOfFinancialAssetsAtAmortisedCost" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">323,981</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B00050</td> 
						<td><span class="zh">　處分按攤銷後成本衡量之金融資產</span><span class="en">　Proceeds from disposal of financial assets at amortised cost</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:ProceedsFromDisposalOfFinancialAssetsAtAmortisedCost" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">95,351</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ProceedsFromDisposalOfFinancialAssetsAtAmortisedCost" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B02200</td> 
						<td><span class="zh">　對子公司之收購（扣除所取得之現金）</span><span class="en">　Net cash flow from acquisition of subsidiaries</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,288,413</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,514,398</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B02300</td> 
						<td><span class="zh">　處分子公司</span><span class="en">　Proceeds from disposal of subsidiaries</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">24,000</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B02700</td> 
						<td><span class="zh">　取得不動產、廠房及設備</span><span class="en">　Acquisition of property, plant and equipment</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">256,300</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">187,760</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B02800</td> 
						<td><span class="zh">　處分不動產、廠房及設備</span><span class="en">　Proceeds from disposal of property, plant and equipment</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,372</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">37,953</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B03700</td> 
						<td><span class="zh">　存出保證金增加</span><span class="en">　Increase in refundable deposits</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseInRefundableDeposits" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseInRefundableDeposits" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">10,805</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B03800</td> 
						<td><span class="zh">　存出保證金減少</span><span class="en">　Decrease in refundable deposits</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:DecreaseInRefundableDeposits" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,375</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:DecreaseInRefundableDeposits" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B04200</td> 
						<td><span class="zh">　其他應收款減少</span><span class="en">　Decrease in other receivables</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:DecreaseInOtherReceivables" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:DecreaseInOtherReceivables" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">73,005</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B04500</td> 
						<td><span class="zh">　取得無形資產</span><span class="en">　Acquisition of intangible assets</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,132,481</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">5,410</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B05000</td> 
						<td><span class="zh">　因合併產生之現金流入</span><span class="en">　Net cash inflows from business combination</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:NetCashInflowsFromBusinessCombination" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">288,423</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:NetCashInflowsFromBusinessCombination" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B06700</td> 
						<td><span class="zh">　其他非流動資產增加</span><span class="en">　Increase in other non-current assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseInOtherAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,547</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseInOtherAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">14,712</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B07100</td> 
						<td><span class="zh">　預付設備款增加</span><span class="en">　Increase in prepayments for business facilities</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseInPrepaymentsForBusinessFacilities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">41,405</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseInPrepaymentsForBusinessFacilities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">7,045</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">BBBB</td> 
						<td><span class="zh">　投資活動之淨現金流入（流出）</span><span class="en">　Net cash flows from (used in) investing activities</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:NetCashFlowsFromUsedInInvestingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">2,457,585</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:NetCashFlowsFromUsedInInvestingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,281,191</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">籌資活動之現金流量</span><span class="en">Cash flows from (used in) financing activities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C00100</td> 
						<td><span class="zh">　短期借款增加</span><span class="en">　Increase in short-term loans</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseInShortTermLoans" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseInShortTermLoans" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">772,328</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C00200</td> 
						<td><span class="zh">　短期借款減少</span><span class="en">　Decrease in short-term loans</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseInShortTermLoans" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,397,782</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:DecreaseInShortTermLoans" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C01200</td> 
						<td><span class="zh">　發行公司債</span><span class="en">　Proceeds from issuing bonds</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ProceedsFromIssuingBonds" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,023,360</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ProceedsFromIssuingBonds" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">844,998</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C01600</td> 
						<td><span class="zh">　舉借長期借款</span><span class="en">　Proceeds from long-term debt</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ProceedsFromLongTermDebt" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,781,000</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ProceedsFromLongTermDebt" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,709,273</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C01700</td> 
						<td><span class="zh">　償還長期借款</span><span class="en">　Repayments of long-term debt</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:RepaymentsOfLongTermDebt" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">5,101,136</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:RepaymentsOfLongTermDebt" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,878,472</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C04020</td> 
						<td><span class="zh">　租賃本金償還</span><span class="en">　Payments of lease liabilities</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">74,747</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">37,227</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C04300</td> 
						<td><span class="zh">　其他非流動負債增加</span><span class="en">　Increase in other non-current liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseInOtherLiabilities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseInOtherLiabilities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">557</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C04400</td> 
						<td><span class="zh">　其他非流動負債減少</span><span class="en">　Decrease in other non-current liabilities</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseInOtherLiabilities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">3,119</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:DecreaseInOtherLiabilities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C04500</td> 
						<td><span class="zh">　發放現金股利</span><span class="en">　Cash dividends paid</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:DividendsPaidClassifiedAsFinancingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">619,134</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:DividendsPaidClassifiedAsFinancingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">238,802</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C04800</td> 
						<td><span class="zh">　員工執行認股權</span><span class="en">　Exercise of employee share options</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ExerciseOfEmployeeShareOptions" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">26,444</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ExerciseOfEmployeeShareOptions" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,896</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C04900</td> 
						<td><span class="zh">　庫藏股票買回成本</span><span class="en">　Payments to acquire treasury shares</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:PaymentsToAcquireTreasuryShares" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:PaymentsToAcquireTreasuryShares" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">53,092</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C05100</td> 
						<td><span class="zh">　員工購買庫藏股</span><span class="en">　Treasury shares sold to employees</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:TreasurySharesSoldToEmployees" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,492</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:TreasurySharesSoldToEmployees" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C05600</td> 
						<td><span class="zh">　支付之利息</span><span class="en">　Interest paid</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">156,006</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">105,040</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C05800</td> 
						<td><span class="zh">　非控制權益變動</span><span class="en">　Change in non-controlling interests</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ChangeInNoncontrollingInterests" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">73,405</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ChangeInNoncontrollingInterests" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">576,381</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">CCCC</td> 
						<td><span class="zh">　籌資活動之淨現金流入（流出）</span><span class="en">　Net cash flows from (used in) financing activities</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:CashFlowsFromUsedInFinancingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">2,440,223</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:CashFlowsFromUsedInFinancingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,594,800</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">DDDD</td> 
						<td><span class="zh">匯率變動對現金及約當現金之影響</span><span class="en">Effect of exchange rate changes on cash and cash equivalents</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">56,126</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">46,887</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">EEEE</td> 
						<td><span class="zh">本期現金及約當現金增加（減少）數</span><span class="en">Net increase (decrease) in cash and cash equivalents</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">228,025</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,370,570</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">E00100</td> 
						<td><span class="zh">期初現金及約當現金餘額</span><span class="en">Cash and cash equivalents at beginning of period</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:CashAndCashEquivalentsAtBeginningOfPeriod" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,281,319</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:CashAndCashEquivalentsAtBeginningOfPeriod" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">910,749</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">E00200</td> 
						<td><span class="zh">期末現金及約當現金餘額</span><span class="en">Cash and cash equivalents at end of period</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:CashAndCashEquivalentsAtEndOfPeriod" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,053,294</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:CashAndCashEquivalentsAtEndOfPeriod" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,281,319</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">E00210</td> 
						<td><span class="zh">　資產負債表帳列之現金及約當現金</span><span class="en">　Cash and cash equivalents reported in the statement of financial position</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,053,294</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,281,319</ix:nonFraction> </pre></td>
					</tr> 

				</table> 
				<br /> 
			<!-- 當期權益變動表 -->
			<div id="StatementsOfChangeInEquity"></div> 
			<div class="rptidx"><span class="zh">單位：新臺幣仟元</span><span class="en">Unit: NT$ thousands</span></div> 
				<table style="width:150%"> 
					<tr> 
						<th colspan="32"> 
							<span class="zh">當期權益變動表</span><span class="en">Statements of Change in Equity</span> 
						</th> 
					</tr> 
					<tr> 
						<th colspan='2' rowspan='2'></th> 
						<th>3110</th>
						<th>3140</th>
						<th>3100</th>
						<th>3200</th>
						<th>3310</th>
						<th>3320</th>
						<th>3350</th>
						<th>3300</th>
						<th>3410</th>
						<th>3420</th>
						<th>3445</th>
						<th>3400</th>
						<th>3500</th>
						<th>31XX</th>
						<th>36XX</th>
						<th>3XXX</th>
					</tr> 
					<tr> 
						<th> 
							<span class="zh">普通股股本</span> 
							<span class="en">　　　　　Ordinary share</span> 
						</th>
						<th> 
							<span class="zh">預收股本</span> 
							<span class="en">　　　　　Advance receipts for share capital</span> 
						</th>
						<th> 
							<span class="zh">股本合計</span> 
							<span class="en">　　　　Total share capital</span> 
						</th>
						<th> 
							<span class="zh">資本公積</span> 
							<span class="en">　　　　Capital surplus</span> 
						</th>
						<th> 
							<span class="zh">法定盈餘公積</span> 
							<span class="en">　　　　　Legal reserve</span> 
						</th>
						<th> 
							<span class="zh">特別盈餘公積</span> 
							<span class="en">　　　　　Special reserve</span> 
						</th>
						<th> 
							<span class="zh">未分配盈餘（或待彌補虧損）</span> 
							<span class="en">　　　　　Unappropriated retained earnings (accumulated deficit)</span> 
						</th>
						<th> 
							<span class="zh">保留盈餘合計</span> 
							<span class="en">　　　　Total retained earnings</span> 
						</th>
						<th> 
							<span class="zh">國外營運機構財務報表換算之兌換差額</span> 
							<span class="en">　　　　　Exchange differences on translation of foreign financial statements</span> 
						</th>
						<th> 
							<span class="zh">透過其他綜合損益按公允價值衡量之金融資產未實現評價(損)益</span> 
							<span class="en">　　　　　Unrealised gains (losses) on financial assets measured at fair value through other comprehensive income</span> 
						</th>
						<th> 
							<span class="zh">確定福利計畫再衡量數</span> 
							<span class="en">　　　　　Gains (losses) on remeasurements of defined benefit</span> 
						</th>
						<th> 
							<span class="zh">其他權益項目合計</span> 
							<span class="en">　　　　Total other equity interest</span> 
						</th>
						<th> 
							<span class="zh">庫藏股票</span> 
							<span class="en">　　　　Treasury shares</span> 
						</th>
						<th> 
							<span class="zh">歸屬於母公司業主之權益總計</span> 
							<span class="en">　　　Total equity attributable to owners of parent</span> 
						</th>
						<th> 
							<span class="zh">非控制權益</span> 
							<span class="en">　　　Non-controlling interests</span> 
						</th>
						<th> 
							<span class="zh">權益總額</span> 
							<span class="en">　　Total equity</span> 
						</th>
					</tr> 
					<tr> 
						<td>A1</td> 
						<td> 
							<span class="zh">期初餘額</span> 
							<span class="en">　Equity at beginning of period</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">753,815</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_AdvanceReceiptsForShareCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,107</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">756,922</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,236,380</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">216,436</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,919</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,308,664</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,549,019</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">35,489</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,900</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_ReserveOfRemeasurementsOfDefinedBenefitPlansMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,504</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">39,093</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">53,092</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,528,322</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">612,134</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,140,456</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>B1</td> 
						<td> 
							<span class="zh">提列法定盈餘公積</span> 
							<span class="en">　　Legal reserve appropriated</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20230101To20231231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">139,065</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20230101To20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">139,065</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20230101To20231231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>B5</td> 
						<td> 
							<span class="zh">普通股現金股利</span> 
							<span class="en">　　Cash dividends of ordinary share</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20230101To20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">619,134</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20230101To20231231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">619,134</ix:nonFraction>)</pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">619,134</ix:nonFraction>)</pre></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">619,134</ix:nonFraction>)</pre></td>
					</tr>
					<tr> 
						<td>B9</td> 
						<td> 
							<span class="zh">普通股股票股利</span> 
							<span class="en">　　Stock dividends of ordinary share</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:StockDividendsOfOrdinaryShare" contextRef="From20230101To20231231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">231,410</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:StockDividendsOfOrdinaryShare" contextRef="From20230101To20231231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">231,410</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:StockDividendsOfOrdinaryShare" contextRef="From20230101To20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">231,410</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:StockDividendsOfOrdinaryShare" contextRef="From20230101To20231231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">231,410</ix:nonFraction>)</pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:StockDividendsOfOrdinaryShare" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:StockDividendsOfOrdinaryShare" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>B17</td> 
						<td> 
							<span class="zh">特別盈餘公積迴轉</span> 
							<span class="en">　　Reversal of special reserve</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:ReversalOfSpecialReserve" contextRef="From20230101To20231231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">23,919</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ReversalOfSpecialReserve" contextRef="From20230101To20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,919</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ReversalOfSpecialReserve" contextRef="From20230101To20231231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ReversalOfSpecialReserve" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ReversalOfSpecialReserve" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>C5</td> 
						<td> 
							<span class="zh">因發行可轉換公司債（特別股）認列權益組成項目－認股權而產生者</span> 
							<span class="en">　　Due to recognition of equity component of convertible bonds (preference share) issued</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:DueToRecognitionOfEquityComponentOfConvertibleBondsPreferenceShareIssued" contextRef="From20230101To20231231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">392,062</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:DueToRecognitionOfEquityComponentOfConvertibleBondsPreferenceShareIssued" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">392,062</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:DueToRecognitionOfEquityComponentOfConvertibleBondsPreferenceShareIssued" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">392,062</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>D1</td> 
						<td> 
							<span class="zh">本期淨利（淨損）</span> 
							<span class="en">　Profit (loss)</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20230101To20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,030,142</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20230101To20231231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,030,142</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,030,142</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20230101To20231231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">41,779</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,071,921</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>D3</td> 
						<td> 
							<span class="zh">本期其他綜合損益</span> 
							<span class="en">　Other comprehensive income</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20230101To20231231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">40,906</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20230101To20231231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">6,192</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20230101To20231231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">34,714</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">34,714</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20230101To20231231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">435</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">34,279</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>D5</td> 
						<td> 
							<span class="zh">本期綜合損益總額</span> 
							<span class="en">　Total comprehensive income</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20230101To20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,030,142</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20230101To20231231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,030,142</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20230101To20231231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">40,906</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20230101To20231231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">6,192</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20230101To20231231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">34,714</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,064,856</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20230101To20231231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">41,344</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,106,200</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>I1</td> 
						<td> 
							<span class="zh">可轉換公司債轉換</span> 
							<span class="en">　Conversion of convertible bonds</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ConversionOfConvertibleBonds" contextRef="From20230101To20231231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">27,863</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:ConversionOfConvertibleBonds" contextRef="From20230101To20231231_AdvanceReceiptsForShareCapitalMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">3,064</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ConversionOfConvertibleBonds" contextRef="From20230101To20231231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">24,799</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ConversionOfConvertibleBonds" contextRef="From20230101To20231231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">644,607</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ConversionOfConvertibleBonds" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">669,406</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ConversionOfConvertibleBonds" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">669,406</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>M5</td> 
						<td> 
							<span class="zh">實際取得或處分子公司股權價格與帳面價值差額</span> 
							<span class="en">　Difference between consideration and carrying amount of subsidiaries acquired or disposed</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:DifferenceBetweenConsiderationAndCarryingAmountOfSubsidiariesAcquiredOrDisposed" contextRef="From20230101To20231231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">872,616</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:DifferenceBetweenConsiderationAndCarryingAmountOfSubsidiariesAcquiredOrDisposed" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">872,616</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:DifferenceBetweenConsiderationAndCarryingAmountOfSubsidiariesAcquiredOrDisposed" contextRef="From20230101To20231231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,993,616</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:DifferenceBetweenConsiderationAndCarryingAmountOfSubsidiariesAcquiredOrDisposed" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,866,232</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>M7</td> 
						<td> 
							<span class="zh">對子公司所有權權益變動</span> 
							<span class="en">　Changes in ownership interests in subsidiaries</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20230101To20231231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">47,125</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">47,125</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20230101To20231231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">29,375</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">76,500</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>N1</td> 
						<td> 
							<span class="zh">股份基礎給付</span> 
							<span class="en">　Share-based payments</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20230101To20231231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,040</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20230101To20231231_AdvanceReceiptsForShareCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">810</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20230101To20231231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,850</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20230101To20231231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">120,192</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">122,042</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20230101To20231231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,215</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">129,257</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>O1</td> 
						<td> 
							<span class="zh">非控制權益增減</span> 
							<span class="en">　Changes in non-controlling interests</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInNoncontrollingInterests" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:ChangesInNoncontrollingInterests" contextRef="From20230101To20231231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">2,660</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:ChangesInNoncontrollingInterests" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">2,660</ix:nonFraction>)</pre></td>
					</tr>
					<tr> 
						<td>T1</td> 
						<td> 
							<span class="zh">其他</span> 
							<span class="en">　Others</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:Others-IncreaseDecreaseInEquity" contextRef="From20230101To20231231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,368</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:Others-IncreaseDecreaseInEquity" contextRef="From20230101To20231231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,124</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:Others-IncreaseDecreaseInEquity" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,492</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:Others-IncreaseDecreaseInEquity" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,492</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>Y1</td> 
						<td> 
							<span class="zh">權益增加(減少)總額</span> 
							<span class="en">　Total increase (decrease) in equity</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">260,313</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_AdvanceReceiptsForShareCapitalMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">2,254</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">258,059</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,081,970</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">139,065</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">23,919</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,064,452</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,179,598</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">40,906</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">6,192</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">34,714</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,124</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,556,465</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,068,890</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,625,355</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>Z1</td> 
						<td> 
							<span class="zh">期末餘額</span> 
							<span class="en">　Equity at end of period</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,014,128</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_AdvanceReceiptsForShareCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">853</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,014,981</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,318,350</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">355,501</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,373,116</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,728,617</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">76,395</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,900</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,312</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">73,807</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">50,968</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,084,787</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,681,024</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">11,765,811</ix:nonFraction> </pre></td>
					</tr>
				</table> 
				<br /> 
			<!-- 去年同期權益變動表 -->
			<div class="rptidx"><span class="zh">單位：新臺幣仟元</span><span class="en">Unit: NT$ thousands</span></div> 
				<table style="width:150%"> 
					<tr> 
						<th colspan="32"> 
							<span class="zh">去年同期權益變動表</span><span class="en"> Last year's Statements of Change in Equity </span> 
						</th> 
					</tr> 
					<tr> 
						<th colspan='2' rowspan='2'></th> 
						<th>3110</th>
						<th>3140</th>
						<th>3100</th>
						<th>3200</th>
						<th>3310</th>
						<th>3320</th>
						<th>3350</th>
						<th>3300</th>
						<th>3410</th>
						<th>3420</th>
						<th>3445</th>
						<th>3400</th>
						<th>3500</th>
						<th>31XX</th>
						<th>36XX</th>
						<th>3XXX</th>
					</tr> 
					<tr> 
						<th> 
							<span class="zh">普通股股本</span> 
							<span class="en">　　　　　Ordinary share</span> 
						</th>
						<th> 
							<span class="zh">預收股本</span> 
							<span class="en">　　　　　Advance receipts for share capital</span> 
						</th>
						<th> 
							<span class="zh">股本合計</span> 
							<span class="en">　　　　Total share capital</span> 
						</th>
						<th> 
							<span class="zh">資本公積</span> 
							<span class="en">　　　　Capital surplus</span> 
						</th>
						<th> 
							<span class="zh">法定盈餘公積</span> 
							<span class="en">　　　　　Legal reserve</span> 
						</th>
						<th> 
							<span class="zh">特別盈餘公積</span> 
							<span class="en">　　　　　Special reserve</span> 
						</th>
						<th> 
							<span class="zh">未分配盈餘（或待彌補虧損）</span> 
							<span class="en">　　　　　Unappropriated retained earnings (accumulated deficit)</span> 
						</th>
						<th> 
							<span class="zh">保留盈餘合計</span> 
							<span class="en">　　　　Total retained earnings</span> 
						</th>
						<th> 
							<span class="zh">國外營運機構財務報表換算之兌換差額</span> 
							<span class="en">　　　　　Exchange differences on translation of foreign financial statements</span> 
						</th>
						<th> 
							<span class="zh">透過其他綜合損益按公允價值衡量之金融資產未實現評價(損)益</span> 
							<span class="en">　　　　　Unrealised gains (losses) on financial assets measured at fair value through other comprehensive income</span> 
						</th>
						<th> 
							<span class="zh">確定福利計畫再衡量數</span> 
							<span class="en">　　　　　Gains (losses) on remeasurements of defined benefit</span> 
						</th>
						<th> 
							<span class="zh">其他權益項目合計</span> 
							<span class="en">　　　　Total other equity interest</span> 
						</th>
						<th> 
							<span class="zh">庫藏股票</span> 
							<span class="en">　　　　Treasury shares</span> 
						</th>
						<th> 
							<span class="zh">歸屬於母公司業主之權益總計</span> 
							<span class="en">　　　Total equity attributable to owners of parent</span> 
						</th>
						<th> 
							<span class="zh">非控制權益</span> 
							<span class="en">　　　Non-controlling interests</span> 
						</th>
						<th> 
							<span class="zh">權益總額</span> 
							<span class="en">　　Total equity</span> 
						</th>
					</tr> 
					<tr> 
						<td>A1</td> 
						<td> 
							<span class="zh">期初餘額</span> 
							<span class="en">　Equity at beginning of period</span> 
						</td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">684,123</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_AdvanceReceiptsForShareCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">660</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">684,783</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,025,985</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">141,462</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,900</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,319,331</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,465,693</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">23,555</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,900</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_ReserveOfRemeasurementsOfDefinedBenefitPlansMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,535</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">23,920</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,152,541</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,152,541</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>B1</td> 
						<td> 
							<span class="zh">提列法定盈餘公積</span> 
							<span class="en">　　Legal reserve appropriated</span> 
						</td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20220101To20221231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">74,974</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">74,974</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:LegalReserveAppropriated" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>B3</td> 
						<td> 
							<span class="zh">提列特別盈餘公積</span> 
							<span class="en">　　Special reserve appropriated</span> 
						</td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20220101To20221231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">19,019</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">19,019</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:SpecialReserveAppropriated" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>B5</td> 
						<td> 
							<span class="zh">普通股現金股利</span> 
							<span class="en">　　Cash dividends of ordinary share</span> 
						</td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">238,802</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">238,802</ix:nonFraction>)</pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">238,802</ix:nonFraction>)</pre></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:CashDividendsOfOrdinaryShare" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">238,802</ix:nonFraction>)</pre></td>
					</tr>
					<tr> 
						<td>B9</td> 
						<td> 
							<span class="zh">普通股股票股利</span> 
							<span class="en">　　Stock dividends of ordinary share</span> 
						</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:StockDividendsOfOrdinaryShare" contextRef="From20220101To20221231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">68,522</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:StockDividendsOfOrdinaryShare" contextRef="From20220101To20221231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">68,522</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:StockDividendsOfOrdinaryShare" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">68,522</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:StockDividendsOfOrdinaryShare" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">68,522</ix:nonFraction>)</pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:StockDividendsOfOrdinaryShare" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:StockDividendsOfOrdinaryShare" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>C5</td> 
						<td> 
							<span class="zh">因發行可轉換公司債（特別股）認列權益組成項目－認股權而產生者</span> 
							<span class="en">　　Due to recognition of equity component of convertible bonds (preference share) issued</span> 
						</td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:DueToRecognitionOfEquityComponentOfConvertibleBondsPreferenceShareIssued" contextRef="From20220101To20221231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">94,679</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:DueToRecognitionOfEquityComponentOfConvertibleBondsPreferenceShareIssued" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">94,679</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:DueToRecognitionOfEquityComponentOfConvertibleBondsPreferenceShareIssued" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">94,679</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>D1</td> 
						<td> 
							<span class="zh">本期淨利（淨損）</span> 
							<span class="en">　Profit (loss)</span> 
						</td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,391,916</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,391,916</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,391,916</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,609</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,401,525</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>D3</td> 
						<td> 
							<span class="zh">本期其他綜合損益</span> 
							<span class="en">　Other comprehensive income</span> 
						</td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">15</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">15</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">59,044</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,969</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">63,013</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">63,028</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">63,028</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>D5</td> 
						<td> 
							<span class="zh">本期綜合損益總額</span> 
							<span class="en">　Total comprehensive income</span> 
						</td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,391,931</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,391,931</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">59,044</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,969</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">63,013</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,454,944</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,609</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,464,553</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>I1</td> 
						<td> 
							<span class="zh">可轉換公司債轉換</span> 
							<span class="en">　Conversion of convertible bonds</span> 
						</td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ConversionOfConvertibleBonds" contextRef="From20220101To20221231_AdvanceReceiptsForShareCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,067</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ConversionOfConvertibleBonds" contextRef="From20220101To20221231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,067</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ConversionOfConvertibleBonds" contextRef="From20220101To20221231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">80,403</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ConversionOfConvertibleBonds" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">83,470</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ConversionOfConvertibleBonds" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">83,470</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>L1</td> 
						<td> 
							<span class="zh">庫藏股買回</span> 
							<span class="en">　Purchase of treasury shares</span> 
						</td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:PurchaseOfTreasuryShares" contextRef="From20220101To20221231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">53,092</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:PurchaseOfTreasuryShares" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">53,092</ix:nonFraction>)</pre></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:PurchaseOfTreasuryShares" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">53,092</ix:nonFraction>)</pre></td>
					</tr>
					<tr> 
						<td>M5</td> 
						<td> 
							<span class="zh">實際取得或處分子公司股權價格與帳面價值差額</span> 
							<span class="en">　Difference between consideration and carrying amount of subsidiaries acquired or disposed</span> 
						</td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:DifferenceBetweenConsiderationAndCarryingAmountOfSubsidiariesAcquiredOrDisposed" contextRef="From20220101To20221231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,177</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:DifferenceBetweenConsiderationAndCarryingAmountOfSubsidiariesAcquiredOrDisposed" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,177</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:DifferenceBetweenConsiderationAndCarryingAmountOfSubsidiariesAcquiredOrDisposed" contextRef="From20220101To20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">21,823</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:DifferenceBetweenConsiderationAndCarryingAmountOfSubsidiariesAcquiredOrDisposed" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">24,000</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>M7</td> 
						<td> 
							<span class="zh">對子公司所有權權益變動</span> 
							<span class="en">　Changes in ownership interests in subsidiaries</span> 
						</td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,281</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,281</ix:nonFraction>)</pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,281</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20220101To20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">578,666</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:ChangesInOwnershipInterestsInSubsidiaries" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">577,385</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>N1</td> 
						<td> 
							<span class="zh">股份基礎給付</span> 
							<span class="en">　Share-based payments</span> 
						</td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20220101To20221231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,170</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20220101To20221231_AdvanceReceiptsForShareCapitalMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">620</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20220101To20221231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">550</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20220101To20221231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">33,136</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">33,686</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20220101To20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,036</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">35,722</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>Y1</td> 
						<td> 
							<span class="zh">權益增加(減少)總額</span> 
							<span class="en">　Total increase (decrease) in equity</span> 
						</td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">69,692</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_AdvanceReceiptsForShareCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,447</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">72,139</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">210,395</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">74,974</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">19,019</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">989,333</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,083,326</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">59,044</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,969</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">63,013</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">53,092</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,375,781</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">612,134</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,987,915</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>Z1</td> 
						<td> 
							<span class="zh">期末餘額</span> 
							<span class="en">　Equity at end of period</span> 
						</td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">753,815</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_AdvanceReceiptsForShareCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,107</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">756,922</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,236,380</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_StatutoryReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">216,436</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_SpecialReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,919</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,308,664</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,549,019</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">35,489</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,900</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,504</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">39,093</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_TreasurySharesMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">53,092</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,528,322</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_NoncontrollingInterestsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">612,134</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,140,456</ix:nonFraction> </pre></td>
					</tr>

				</table> 
				<br /> 
			<!-- 會計師查核報告 -->	
			<div id="ReportOfIndependentAuditors"></div> 
			<span class="zh">
			<div class="rptidx">單位：新臺幣仟元</div> 
				<table> 
					<tr>
						<th colspan="3">會計師查核（核閱）報告</th> 
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 會計師事務所名稱</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:AccountantName" contextRef="AsOf20240307" xml:lang="zh" escape="true">安永聯合會計師事務所</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 簽證會計師名稱 1</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:AssuranceAccountantName1" contextRef="AsOf20240307" xml:lang="zh" escape="true">洪國森</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 簽證會計師名稱 2</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:AssuranceAccountantName2" contextRef="AsOf20240307" xml:lang="zh" escape="true">陳明宏</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 核閱或查核日期</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:ReviewAuditDate" contextRef="AsOf20240307" xml:lang="zh" escape="true">2024-03-07</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 報告類型</th> 
						<td colspan="2"></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　　 查核報告</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:AuditReport" contextRef="AsOf20240307" xml:lang="zh" escape="true">Y</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 核閱或查核報告類型</th> 
						<td colspan="2"></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　　 無保留意見/結論</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:UnqualifiedOpinionAbstract" contextRef="AsOf20240307" xml:lang="zh" escape="true">Y</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 報告類型細分</th> 
						<td colspan="2"></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 簡述強調事項內容</th> 
						<td colspan="2"></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 簡述其他事項內容</th> 
						<td colspan="2"></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 會計師查核(核閱)報告內容</th> 
						<td colspan="2"><pre class="note"><ix:nonNumeric name="tifrs-ar:AccountantsReportBody" contextRef="AsOf20240307" xml:lang="zh" escape="true">　　　　　　　　　　　　　　　　　　　　　　 會計師查核報告


保瑞藥業股份有限公司　公鑒：

查核意見

　　保瑞藥業股份有限公司及子公司(以下簡稱保瑞集團)民國一一二年十二月三十一日及民國一一一年十二月三十一日
之合併資產負債表，暨民國一一二年一月一日至十二月三十一日及民國一一一年一月一日至十二月三十一日之合併綜合
損益表、合併權益變動表、合併現金流量表，以及合併財務報表附註(包括重大會計政策彙總)，業經本會計師查核竣事
。

　　依本會計師之意見，上開合併財務報表在所有重大方面係依照證券發行人財務報告編製準則暨經金融監督管理委員
會認可並發布生效之國際財務報導準則、國際會計準則、國際財務報導解釋及解釋公告編製，足以允當表達保瑞集團民
國一一二年十二月三十一日及民國一一一年十二月三十一日之合併財務狀況，暨民國一一二年一月一日至十二月三十一
日及民國一一一年一月一日至十二月三十一日之合併財務績效及合併現金流量。

查核意見之基礎

　　本會計師係依照會計師查核簽證財務報表規則及審計準則執行查核工作。本會計師於該等準則下之責任將於會計師
查核合併財務報表之責任段進一步說明。本會計師所隸屬事務所受獨立性規範之人員已依會計師職業道德規範，與保瑞
集團保持超然獨立，並履行該規範之其他責任。本會計師相信已取得足夠及適切之查核證據，以作為表示查核意見之基
礎。

關鍵查核事項

　　關鍵查核事項係指依本會計師之專業判斷，對保瑞集團民國一一二年度合併財務報表之查核最為重要之事項。該等
事項已於查核合併財務報表整體及形成查核意見之過程中予以因應，本會計師並不對該等事項單獨表示意見。

存貨評價

　　截至民國一一二年十二月三十一日止，保瑞集團存貨淨額為2,156,134仟元，占合併資產總額9％，其對財務報表係
屬重大。原物料、在製品及半成品，管理階層會考量產品市場需求訂單及可能銷售狀況，以庫齡天數來評估呆滯金額；
經銷商品及自製製成品，受查公司考量該產品之有效期限會影響存貨銷售情形，故以效期天數來評估呆滯金額。因存貨
淨變現價值計算複雜，本會計師因此決定將備抵存貨跌價損失評估列為關鍵查核事項。

　　本會計師之查核程序包括(但不限於)了解並測試管理階層針對存貨所建立之內部控制的有效性、及評估管理階層針
對存貨評價所估計之淨變現價值，例如：抽選樣本測試存貨庫齡及效期天數之正確性，及執行實地觀察存貨盤點以確認
存貨之數量及狀態，並分析存貨變動情況；考量產品市場需求訂單，評估管理階層對於呆滯及過時存貨所作之分析與評
估，包括存貨變現的可能性及淨變現價值之估計；並重新計算存貨備抵跌價損失金額之正確性。本會計師亦考量存貨揭
露的適當性，請參閱合併財務報表附註五及六。

收入認列

　　保瑞集團於民國一一二年度認列營業收入14,200,068仟元，主要為代工收入、勞務收入及經銷西藥及保健品收入；
收入認列時點依客戶交易條件而異，此涉及管理階層之重大判斷，本會計師因此決定列為關鍵查核事項。

　　本會計師執行之查核程序包括(但不限於)評估管理階層針對收入認列會計政策之適當性，並對所辨認之履約義務之
收入認列程序進行交易流程了解、評估並測試滿足履約義務收入認列時點攸關之內部控制設計及執行之有效性，並針對
前十大銷售廠商客戶進行分析性程序、選取樣本執行交易細項測試，以確認滿足履約義務收入認列時點之妥適性、在資
產負債表日前後一段時間執行收入截止測試並核對相關憑證，以確認收入認列於適當之期間、檢視資產負債表日後之鉅
額銷貨退回，查明並瞭解其原因及性質、執行普通日記簿分錄測試，本會計師亦考量收入認列揭露之適當性，請參閱合
併財務報表附註四及六。

企業合併

　　保瑞集團於民國一一二年十一月一日（合併基準日)依企業併購法及其他相關法令規定將持有之保瑞聯邦股份有限
公司全部股份以股份轉換方式取得晨暉生物科技股份有限公司發行之新股並取得對其控制，此項併購案依據國際財務報
導準則規定屬反向收購。因該併購交易為反向併購且金額重大，並涉及合併交易辨認，對財務報表之影響重大，本會計
師因此將併購交易列為關鍵查核事項。

　　本會計師之查核程序包括(但不限於)取得股權相關交易協議，評估管理階層認列並衡量此等企業合併交易對價及對
合併者之帳列淨資產帳面金額之合理性，確認交易基準日及相關會計處理是否適當。本會計師亦考量企業合併揭露之適
當性，請參閱合併財務報表附註五及六。

管理階層與治理單位對合併財務報表之責任

　　管理階層之責任係依照證券發行人財務報告編製準則暨經金融監督管理委員會認可並發布生效之國際財務報導準則
、國際會計準則、國際財務報導解釋及解釋公告編製允當表達之合併財務報表，且維持與合併財務報表編製有關之必要
內部控制，以確保合併財務報表未存有導因於舞弊或錯誤之重大不實表達。

　　於編製合併財務報表時，管理階層之責任亦包括評估保瑞集團繼續經營之能力、相關事項之揭露，以及繼續經營會
計基礎之採用，除非管理階層意圖清算保瑞集團或停止營業，或除清算或停業外別無實際可行之其他方案。

　　保瑞集團之治理單位(含審計委員會)負有監督財務報導流程之責任。

會計師查核合併財務報表之責任

　　本會計師查核合併財務報表之目的，係對合併財務報表整體是否存有導因於舞弊或錯誤之重大不實表達取得合理確
信，並出具查核報告。合理確信係高度確信，惟依照審計準則執行之查核工作無法保證必能偵出合併財務報表存有之重
大不實表達。不實表達可能導因於舞弊或錯誤。如不實表達之個別金額或彙總數可合理預期將影響合併財務報表使用者
所作之經濟決策，則被認為具有重大性。

　　本會計師依照審計準則查核時，運用專業判斷及專業懷疑。本會計師亦執行下列工作：

　　1.辨認並評估合併財務報表導因於舞弊或錯誤之重大不實表達風險；對所評估之風險設計及執行適當之因應對策；
　　　並取得足夠及適切之查核證據以作為查核意見之基礎。因舞弊可能涉及共謀、偽造、故意遺漏、不實聲明或踰越
　　　內部控制，故未偵出導因於舞弊之重大不實表達之風險高於導因於錯誤者。

　　2.對與查核攸關之內部控制取得必要之瞭解，以設計當時情況下適當之查核程序，惟其目的非對保瑞集團內部控制
　　　之有效性表示意見。

　　3.評估管理階層所採用會計政策之適當性，及其所作會計估計與相關揭露之合理性。

　　4.依據所取得之查核證據，對管理階層採用繼續經營會計基礎之適當性，以及使保瑞集團繼續經營之能力可能產生
　　　重大疑慮之事件或情況是否存在重大不確定性，作出結論。本會計師若認為該等事件或情況存在重大不確定性，
　　　則須於查核報告中提醒合併財務報表使用者注意合併財務報表之相關揭露，或於該等揭露係屬不適當時修正查核
　　　意見。本會計師之結論係以截至查核報告日所取得之查核證據為基礎。惟未來事件或情況可能導致保瑞集團不再
　　　具有繼續經營之能力。

　　5.評估合併財務報表(包括相關附註)之整體表達、結構及內容，以及合併財務報表是否允當表達相關交易及事件。

　　6.對於集團內組成個體之財務資訊取得足夠及適切之查核證據，以對合併財務報表表示意見。本會計師負責集團查
　　　核案件之指導、監督及執行，並負責形成集團查核意見。

　　本會計師與治理單位溝通之事項，包括所規劃之查核範圍及時間，以及重大查核發現(包括於查核過程中所辨認之
內部控制顯著缺失)。

　　本會計師亦向治理單位提供本會計師所隸屬事務所受獨立性規範之人員已遵循會計師職業道德規範中有關獨立性之
聲明，並與治理單位溝通所有可能被認為會影響會計師獨立性之關係及其他事項(包括相關防護措施)。

　　本會計師從與治理單位溝通之事項中，決定對保瑞集團民國一一二年度合併財務報表查核之關鍵查核事項。本會計
師於查核報告中敘明該等事項，除非法令不允許公開揭露特定事項，或在極罕見情況下，本會計師決定不於查核報告中
溝通特定事項，因可合理預期此溝通所產生之負面影響大於所增進之公眾利益。

其他

　　保瑞藥業股份有限公司已編製民國一一二年及一一一年度之個體財務報告，並經本會計師出具無保留意見之查核報
告在案，備供參考。






　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　安 永 聯 合 會 計 師 事 務 所
　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　主管機關核准辦理公開發行公司財務報告
　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　查核簽證文號：金管證審字第1100352201號
　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　金管證六字第1060027042號

　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　洪 國 森

　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　會計師：

　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　陳 明 宏

　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　中華民國 一一三 年 三 月 七 日

</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止採用其他會計師查核意見(核閱報告)之子公司期末資產總額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:EndingBalanceOfAssetsOfSubsidiariesWhoseFinancialStatementsWereAuditedOrReviewedByOtherIndependentAccountants" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止採用其他會計師查核意見(核閱報告)之子公司營業收入淨額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:TotalYearToDateRevenuesOfSubsidiariesWhoseFinancialStatementsWereAuditedOrReviewedByOtherIndependentAccountants" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止採用其他會計師查核意見(核閱報告)之採用權益法之投資期末餘額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:EndingBalanceOfInvestmentsAccountedForUsingEquityMethodWhoseFinancialStatementsWereAuditedOrReviewedByOtherIndependentAccountants" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止採用其他會計師查核意見(核閱報告)之採用權益法之投資當期認列關聯企業及合資損益之份額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:ShareOfProfitLossForTheQuarterOfAssociatesAndJointVenturesAccountedForUsingEquityMethodWhoseFinancialStatementsWereAuditedOrReviewedByOtherIndependentAccountants" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止未經會計師查核(核閱)之子公司期末資產總額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:EndingBalanceOfAssetsOfSubsidiariesWhoseFinancialStatementsWereOnUnauditedOrUnreviewed" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止未經會計師查核(核閱)之子公司綜合損益金額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:YearToDateComprehensiveIncomeOfSubsidiariesWhoseFinancialStatementsWereUnauditedOrUnreviewed" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止未經會計師查核(核閱)之採用權益法之投資期末餘額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:EndingBalanceOfInvestmentsAccountedForUsingEquityMethodWhoseFinancialStatementsWereUnauditedOrUnreviewed" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止未經會計師查核(核閱)之採用權益法之投資當期認列關聯企業及合資損益之份額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:ShareOfYearToDateProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodWhoseFinancialStatementsWereUnauditedOrUnreviewed" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
				</table>
			</span>

			<br />
			<span class="zh">
			<div class="title">財務報表附註</div>
			<div id="HistoryAndOrganization">
				<table style="width:90%">
					<tr>
						<th colspan='5' style="text-align:left">公司沿革及業務範圍</th>
					</tr> 
					<tr>
						<td>　 公司沿革及業務範圍</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:HistoryAndOrganization" contextRef="From20230101To20231231" escape="true">

1.本公司於民國九十六年六月十二日核准設立，原名「保瑞國際股份有限公司」，於民國一○二年六月更名為「保瑞藥業股份有限公司」
　。主要營業地址原為台北市內湖區行愛路69號，於民國一一○年二月二日變更為台北市內湖區瑞光路26巷36弄2號6樓。本公司主要經營
　業務為代理經銷西藥產品、西藥製造、新藥開發、保健食品研發及銷售。本公司股票自民國一一二年十二月十九日起於臺灣證券交易所
　上市買賣。



</ix:nonNumeric></pre></td>
					</tr>
				</table>
			</div>
			<br />
			<div id="DateAndProceduresOfAuthorisationForIssueOfFinancialStatements">
				<table style="width:90%">
					<tr>
						<th colspan='5' style="text-align:left">通過財報之日期及程序</th>
					</tr> 
					<tr>
						<td>　 通過財報之日期及程序</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:DateAndProceduresOfAuthorisationForIssueOfFinancialStatements" contextRef="From20230101To20231231" escape="true">

本公司及子公司(以下簡稱本集團)民國一一二年度及一一一年度之合併財務報告業經董事會於民國一一三年三月七日通過發布。



</ix:nonNumeric></pre></td>
					</tr>
				</table>
			</div>
			<br />
			<div id="ApplicationOfNewlyIssuedOrAmendedStandardsAndInterpretations">
				<table style="width:90%">
					<tr>
						<th colspan='5' style="text-align:left">新發布及修訂準則及解釋之適用</th>
					</tr> 
					<tr>
						<td>　 新發布及修訂準則及解釋之適用</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ApplicationOfNewlyIssuedOrAmendedStandardsAndInterpretations" contextRef="From20230101To20231231" escape="true">

1.首次適用國際財務報導準則而產生之會計政策變動

　本集團已採用金融監督管理委員會(以下簡稱金管會)已認可且自民國一一二年一月一日以後開始之會計年度適用之國際財務報導準則、國
　際會計準則、國際財務報導解釋或解釋公告，新準則及修正之首次適用對本集團並無重大影響。

2.截至財務報告通過發布日為止，本集團尚未採用下列國際會計準則理事會已發布且金管會已認可之新發布、修訂及修正準則或解釋：

　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　 國際會計準則理事會
　 項次　　　　　　　　　 　　　　　　　新發布/修正/修訂準則及解釋　　　　　　　　　　　　　　　　 　　 發布之生效日
　－－－　－－－－－－－－－－－－－－－－－－－－－－－－－－－－－——————————————　－－－－－－－－－－－－
　　 1　　　負債分類為流動或非流動(國際會計準則第1號之修正)　　　　　　　　　　　　　　　　　　　　　 民國113年1月1日
　　 2　　　售後租回中之租賃負債(國際財務報導準則第16號之修正)　　　　　　　　　　　　　　　　　　　　民國113年1月1日
　　 3　　　合約中之非流動負債(國際會計準則第1號之修正)　　　　　　　　　　　　　　　　　　　　　　　 民國113年1月1日
　　 4　　　供應商融資安排(國際會計準則第7號及國際財務報導準則第7號之修正)　　　　　　　　　　　　　　民國113年1月1日

　(1) 負債分類為流動或非流動(國際會計準則第1號之修正)

　　　此係針對會計準則第1號「財務報表之表達」第69段至76段中負債分類為流動或非流動進行修正。 

　(2) 售後租回中之租賃負債(國際財務報導準則第16號之修正)

　　　此係針對國際財務報導準則第16號「租賃」賣方兼承租人於售後租回交易增加額外會計處理以增進準則之一致適用。

　(3) 合約中之非流動負債(國際會計準則第1號之修正)

　　　此修正係增進企業提供有關長期債務合約之資訊。說明對於報導期間後十二個月須遵守之合約約定，不影響該等負債於報導期間結束
　　　日分類為流動或非流動。

　(4) 供應商融資安排(國際會計準則第7號及國際財務報導準則第7號之修正)

　　　此修正除增加供應商融資安排之說明外，並就供應商融資安排新增相關之揭露。

　以上為國際會計準則理事會已發布，金管會已認可且自民國113年1月1日以後開始之會計年度適用之新發布、修訂及修正之準則或解釋，
　本集團評估其對本集團並無重大影響。

3.截至財務報告通過發布日為止，本集團未採用下列國際會計準則理事會已發布但金管會尚未認可之新發布、修訂及修正準則或解釋：

　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　 國際會計準則理事會
　 項次　　　　　　　　　 　　　　　　　新發布/修正/修訂準則及解釋　　　　　　　　　　　　　　　　 　　 發布之生效日
　－－－　－－－－－－－－－－－－－－－－－－－－－－－－－－－－－——————————————　－－－－－－－－－－－－
　　 1　　　國際財務報導準則第10號「合併財務報表」及國際會計準則第28號「投資關聯企業及合資」之　　待國際會計準則理事會決定
　　　　　　修正－投資者與其關聯企業或合資間之資產出售或投入
　　 2　　　國際財務報導準則第17號「保險合約」　　　　　　　　　　　　　　　　　　　　　　　　　　　　民國112年1月1日
　　 3　　　缺乏可兌換性(國際會計準則第21號之修正)　　　　　　　　　　　　　　　　　　　　　　　　　　民國114年1月1日

　(1) 國際財務報導準則第10號「合併財務報表」及國際會計準則第28號「投資關聯企業及合資」之修正－投資者與其關聯企業或合資間之
　　　資產出售或投入

　　　此計畫係為處理國際財務報導準則第10號「合併財務報表」與國際會計準則第28號「投資關聯企業及合資」間，有關以子公司作價投
　　　資關聯企業或合資而喪失控制之不一致。國際會計準則第28號規定投入非貨幣性資產以交換關聯企業或合資之權益時，應依順流交易
　　　之處理方式銷除所產生利益或損失之份額；國際財務報導準則第10號則規定應認列喪失對子公司之控制時之全數利益或損失。此修正
　　　限制國際會計準則第28號之前述規定，當構成國際財務報導準則第3號所定義為業務之資產出售或投入時，其所產生之利益或損失應
　　　全數認列。

　　　此修正亦修改國際財務報導準則第10號使得投資者與其關聯企業或合資間，當出售或投入不構成國際財務報導準則第3號所定義業務
　　　之子公司時，其產生之利益或損失，僅就非屬投資者所享有份額之範圍認列。

　(2) 國際財務報導準則第17號「保險合約」

　　　此準則提供保險合約全面性之模型，含括所有會計相關部分(認列、衡量、表達及揭露原則)，準則之核心為一般模型，於此模型下，
　　　原始認列以履約現金流量及合約服務邊際兩者之合計數衡量保險合約群組；於每一報導期間結束日之帳面金額為剩餘保障負債及已發
　　　生理賠負債兩者之總和。

　　　除一般模型外，並提供具直接參與特性合約之特定適用方法(變動收費法)；及短期合約之簡化法(保費分攤法)。

　　　此準則於民國106年5月發布後，另於民國109年及110年發布修正，該等修正除於過渡條款中將生效日延後2年(亦即由原先民國110年
　　　1月1日延後至民國112年1月1日)並提供額外豁免外，並藉由簡化部分規定而降低採用此準則成本，以及修改部分規定使部分情況更易
　　　於解釋。此準則之生效將取代過渡準則(亦即國際財務報導準則第4號「保險合約」)

　(3) 缺乏可兌換性(國際會計準則第21號之修正)

　　　此修正係說明貨幣間之可兌換性與缺乏可兌換性，及貨幣缺乏可兌換性時之匯率如何決定，並就貨幣缺乏可兌換性時增加額外之揭露
　　　規定。該等修正自民國114年1月1日以後開始之會計年度適用。

　以上國際會計準則理事會已發布但金管會尚未認可之準則或解釋，其實際適用日期以金管會規定為準，新公布或修正準則、或解釋對本集
　團並無重大影響。



</ix:nonNumeric></pre></td>
					</tr>
				</table>
			</div>
			<br />
			<div id="SummaryOfSignificantAccountingPolicies">
				<table style="width:90%">
					<tr>
						<th colspan='5' style="text-align:left">重大會計政策之彙總說明</th>
					</tr> 
					<tr>
						<td>　 遵循聲明</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:StatementOfIFRSAndRelatedRegulationsCompliance" contextRef="From20230101To20231231" escape="true">

本集團民國一一二年度及一一一年度之合併財務報告係依據證券發行人財務報告編製準則及經金管會認可並發布生效之國際財務報導準則、
國際會計準則、國際財務報導解釋及解釋公告編製。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 編製基礎</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:BasisOfPreparation" contextRef="From20230101To20231231" escape="true">

合併財務報表除以公允價值衡量之金融工具外，係以歷史成本為編製基礎。除另行註明者外，合併財務報表均以新台幣仟元為單位。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　 合併報表編製原則</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:PrinciplesOfConsolidation" contextRef="From20230101To20231231" escape="true">

當本公司暴露於來自對被投資者之參與之變動報酬或對該等變動報酬享有權利，且透過其對被投資者之權力有能力影響該等報酬時，控制即
達成。特別是，本公司僅於具有下列三項控制要素時，本公司始控制被投資者：

(1) 對被投資者之權力(亦即具有賦予其現時能力以主導攸關活動之既存權利)
(2) 來自對被投資者之參與之變動報酬之暴險或權利，及
(3) 使用其對被投資者之權力以影響投資者報酬金額之能力

當本公司直接或間接持有少於多數之被投資者表決權或類似權利時，本公司考量所有攸關事實及情況以評估其是否對被投資者具有權力，包
括：

(1) 與被投資者其他表決權持有人間之合約協議
(2) 由其他合約協議所產生之權利
(3) 表決權及潛在表決權

當事實及情況顯示三項控制要素中之一項或多項發生變動時，本公司即重評估是否仍控制被投資者。

子公司自收購日(即本公司取得控制之日)起，即全部編入合併報表中，直到喪失對子公司控制之日為止。子公司財務報表之會計期間及會計
政策與母公司一致。所有集團內部帳戶餘額、交易、因集團內部交易所產生之未實現內部利得與損失及股利，係全數銷除。

對子公司持股之變動，若未喪失對子公司之控制，則該股權變動係以權益交易處理。

子公司綜合損益總額係歸屬至本公司業主及非控制權益，即使非控制權益因而產生虧損餘額亦然。

若本公司喪失對子公司之控制，則

(1) 除列子公司之資產(包括商譽)和負債；
(2) 除列任何非控制權益之帳面金額；
(3) 認列取得對價之公允價值；
(4) 認列所保留任何投資之公允價值；
(5) 認列所產生之差額為當期損益；
(6) 重分類母公司之前認列於其他綜合損益之項目金額為當期損益，或依其他國際財務報導準則之規定直接轉入保留盈餘。



</ix:nonNumeric></pre></td>
					</tr>
				</table>
				<br /> 
				<table style="width:90%"> 
					<tr> 
						<th colspan='30' rowspan='1' style="text-align:left">列入合併財務報表之子公司</th> 
					</tr>
					<tr> 
						<th colspan='1' rowspan='2' style="text-align:center">投資公司名稱</th> 
						<th colspan='1' rowspan='2' style="text-align:center">子公司名稱</th> 
						<th colspan='1' rowspan='2' style="text-align:center">業務性質</th> 
						<th colspan='2' rowspan='1' style="text-align:center">所持股權百分比</th> 
						<th colspan='1' rowspan='2' style="text-align:center">說明</th> 
					</tr>
					<tr> 
						<th colspan='1' rowspan='1' style="text-align:center">本期</th> 
						<th colspan='1' rowspan='1' style="text-align:center">去年同期</th> 
					</tr>
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">聯邦化學製藥(股)公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">西藥製造及批發</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true">本期：(註1)</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">保瑞聯邦(股)公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">西藥批發及保健保養品批發</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">90.44</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true">本期：(註2)</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">益邦製藥(股)公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">西藥製造及代工</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">Bora Pharmaceuticals USA Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">西藥批發</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">Bora Pharmaceutical Services Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">西藥製造及代工</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">50.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">50.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">益邦製藥(股)公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">Bora Pharmaceutical Services Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">西藥製造及代工</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">50.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">50.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">保瑞管理顧問(股)公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">管理顧問</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">保瑞生技(股)公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">生物技術服務、研究發展服務業及西藥製造業</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">65.70</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">65.70</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">保豐生技(股)公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">生物技術服務及管理顧問</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">安成國際藥業(股)公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">西藥製造及批發</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">本公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">晨暉生物科技(股)公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">保健食品研發、製造及銷售</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">35.79</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true">本期：(註2) (註4)</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">安成國際藥業(股)公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">景德製藥(股)公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">西藥製造及代工</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">98.64</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true">本期：(註3)</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">安成國際藥業(股)公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">TWI Pharmaceuticals USA, Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">西藥批發</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">益邦製藥(股)公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">景德製藥(股)公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">西藥製造及代工</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">98.85</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true">本期：(註3)</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">晨暉生物科技(股)公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">Sunway Group Holding Limited</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">投資業務</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true">本期：(註2)</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">晨暉生物科技(股)公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">宸潤行銷(股)公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">保健食品銷售</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">51.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true">本期：(註2)</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">晨暉生物科技(股)公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">保瑞聯邦(股)公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">西藥批發及保健保養品批發</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true">本期：(註2)</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">保瑞聯邦(股)公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">聯邦化學製藥(股)公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">西藥製造及批發</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true">本期：(註1)</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">Sunway Group Holding Limited</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">Sunway Investment (H.K.) Limited</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">投資業務</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true">本期：(註2)</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">Sunway Investment (H.K.) Limited</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">晨泰生物科技(東莞)有限公司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">保健保養品批發零售</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true">本期：(註2)</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan='1'>備註</th>
						<td colspan='7' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Note-TheConsolidatedEntities" contextRef="From20230101To20231231" escape="true">(註1) 考量未來整體發展策略與資源分配，保瑞聯邦(股)公司於民國一一二年七月取得聯邦化學製藥(股)公司中屬於本公司持有之全數股權。
(註2) 本公司為提升研發效能及擴大保健產品組合，於民國一一二年八月二十一日董事會決議通過以持有之保瑞聯邦(股)公司全數股權與晨暉生物科技
　　　(股)公司進行股份轉換，並取得晨暉生物科技(股)公司之35.79%股權，於民國一一二年十一月一日完成換股，並取得對晨暉生物科技(股)公司及
　　　其子公司之控制力，納入本集團合併報表之編制主體中。
(註3) 考量未來整體發展策略與資源分配，益邦製藥(股)公司於民國一一二年七月取得景德製藥(股)公司中屬於安成國際藥業(股)公司持有之全數股權。
(註4) 本公司持有晨暉生物科技(股)公司(以下稱晨暉公司)少於50%表決權，仍對晨暉公司具有控制，此係因本公司自投資晨暉公司之日起，為晨暉公司
　　　單一最大股東，其他股東相對分散，且有能力主導主要攸關活動，故將其列為子公司。</ix:nonNumeric></pre></td>
					</tr> 
				</table> 
			<div style="text-align:center">未列入合併財務報表之子公司</div>
			<div style="text-align:center">無此情形／免揭露</div>
				<br />
				<table style="width:90%">
					<tr>
						<td>　 外幣</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ForeignCurrencies" contextRef="From20230101To20231231" escape="true">

外幣交易

本集團之合併財務報表係以本公司之功能性貨幣新台幣表達。集團內的每一個體係自行決定其功能性貨幣，並以該功能性貨幣衡量其財務報
表。

集團內個體之外幣交易係以交易日匯率換算為其功能性貨幣記錄。於每一報導期間結束日，外幣貨幣性項目以該日收盤匯率換算；以公允價
值衡量之外幣非貨幣性項目，以衡量公允價值當日之匯率換算；以歷史成本衡量之外幣非貨幣性項目，以原始交易日之匯率換算。

除下列所述者外，因交割或換算貨幣性項目所產生之兌換差額，於發生當期認列為損益：

(1) 為取得符合要件之資產所發生之外幣借款，其產生之兌換差額若視為對利息成本之調整者，為借款成本之一部分，予以資本化作為該項
　　資產之成本。
(2) 適用國際財務報導準則第9號「金融工具」之外幣項目，依金融工具之會計政策處理。
(3) 構成報導個體對國外營運機構淨投資一部分之貨幣性項目，所產生之兌換差額原始係認列為其他綜合損益，並於處分該淨投資時，自權
　　益重分類至損益。

當非貨幣性項目之利益或損失認列為其他綜合損益時，該利益或損失之任何兌換組成部分認列為其他綜合損益。當非貨幣性項目之利益或損
失認列為損益時，該利益或損失之任何兌換組成部分認列為損益。

外幣財務報表之換算 

編製合併財務報表時，國外營運機構之資產與負債係以該資產負債表日之收盤匯率換算為新台幣，收益及費損項目係以當期平均匯率換算。
因換算而產生之兌換差額認列為其他綜合損益，並於處分該國外營運機構時，將先前已認列於其他綜合損益並累計於權益項下之單獨組成部
分之累計兌換差額，於認列處分損益時，自權益重分類至損益。涉及對包含國外營運機構之子公司喪失控制之部分處分，及部分處分對包含
國外營運機構之關聯企業或聯合協議之權益後，所保留之權益係一包含國外營運機構之金融資產者，亦按處分處理。

在未喪失控制下部分處分包含國外營運機構之子公司時，按比例將認列於其他綜合損益之累計兌換差額重新歸屬予該國外營運機構之非控制
權益，而不認列為損益；在未喪失重大影響或聯合控制下，部分處分包含國外營運機構之關聯企業或聯合協議時，累計兌換差額則按比例重
分類至損益。

本集團因收購國外營運機構產生之商譽及對其資產與負債帳面金額所作之公允價值調整，視為該國外營運機構之資產及負債，並以其功能性
貨幣列報。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 資產與負債區分流動與非流動之標準</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ClassificationOfCurrentAndNoncurrentAssetsAndLiabilities" contextRef="From20230101To20231231" escape="true">

有下列情況之一者，分類為流動資產，非屬流動資產，則分類為非流動資產：

(1) 預期於其正常營業週期中實現該資產，或意圖將其出售或消耗。
(2) 主要為交易目的而持有該資產。
(3) 預期於報導期間後十二個月內實現該資產。
(4) 現金或約當現金，但於報導期間後至少十二個月將該資產交換或用以清償負債受到限制者除外。

有下列情況之一者，分類為流動負債，非屬流動負債，則分類為非流動負債：

(1) 預期於其正常營業週期中清償該負債。
(2) 主要為交易目的而持有該負債。
(3) 預期於報導期間後十二個月內到期清償該負債。
(4) 於報導期間結束日不具有將該負債之清償遞延至報導期間後至少十二個月之權利。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 現金及約當現金</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CashAndCashEquivalents" contextRef="From20230101To20231231" escape="true">

現金及約當現金係庫存現金、活期存款及可隨時轉換成定額現金且價值變動風險甚小之短期並具高度流動性之定期存款或投資(包括合約期
間三個月內之定期存款)。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 金融工具</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:FinancialInstruments" contextRef="From20230101To20231231" escape="true">

金融資產與金融負債於本集團成為該金融工具合約條款之一方時認列。

符合國際財務報導準則第9號「金融工具」適用範圍之金融資產與金融負債，於原始認列時，係依公允價值衡量，直接可歸屬於金融資產與
金融負債(除分類為透過損益按公允價值衡量之金融資產及金融負債外)取得或發行之交易成本，係從該金融資產及金融負債之公允價值加計
或減除。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　 金融資產</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:FinancialAssets" contextRef="From20230101To20231231" escape="true">

金融資產之認列與衡量

本集團所有慣例交易金融資產之認列與除列，採交易日會計處理。

本集團以下列兩項為基礎將金融資產分類為後續按攤銷後成本衡量、透過其他綜合損益按公允價值衡量或透過損益按公允價值衡量之金融資
產：

A.管理金融資產之經營模式
B.金融資產之合約現金流量特性



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 透過損益按公允價值衡量之金融資產</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:FinancialAssetsAtFairValueThroughProfitOrLoss" contextRef="From20230101To20231231" escape="true">

除前述符合特定條件而按攤銷後成本衡量或透過其他綜合損益按公允價值衡量外，金融資產均採透過損益按公允價值衡量，並以透過損益按
公允價值衡量之金融資產列報於資產負債表。

此類金融資產以公允價值衡量，其再衡量產生之利益或損失認列為損益，該認列為損益之利益或損失包含該金融資產所收取之任何股利或利
息。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 透過其他綜合損益按公允價值衡量之金融資產</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:FinancialAssetsAtFairValueThroughOtherComprehensiveIncome" contextRef="From20230101To20231231" escape="true">

同時符合下列兩條件之金融資產，按透過其他綜合損益按公允價值衡量，並以透過其他綜合損益按公允價值衡量之金融資產列報於資產負債
表：

A.管理金融資產之經營模式：收取合約現金流量及出售金融資產
B.金融資產之合約現金流量特性：現金流量完全為支付本金及流通在外本金金額之利息

此類金融資產相關損益之認列說明如下：

A.除列或重分類前，除減損利益或損失與外幣兌換損益認列於損益外，其利益或損失係認列於其他綜合損益
B.除列時，先前認列於其他綜合損益之累積利益或損失係自權益重分類至損益作為重分類調整
C.以有效利息法(以有效利率乘以金融資產總帳面金額)或下列情況計算之利息，則認列於損益：
　(a) 如屬購入或創始之信用減損金融資產，以信用調整後有效利率乘以金融資產攤銷後成本
　(b) 非屬前者，惟續後變成信用減損者，以有效利率乘以金融資產攤銷後成本

此外，對於屬國際財務報導準則第9號適用範圍之權益工具，且該權益工具既非持有供交易，亦非適用國際財務報導準則第3號之企業合併中
之收購者所認列之或有對價，於原始認列時，選擇(不可撤銷)將其後續公允價值變動列報於其他綜合損益。列報於其他綜合損益中之金額後
續不得移轉至損益(處分該等權益工具時，將列入其他權益項目之累積金額，直接轉入保留盈餘)，並以透過其他綜合損益按公允價值衡量之
金融資產列報於資產負債表。投資之股利則認列於損益，除非該股利明顯代表部分投資成本之回收。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 按攤銷後成本衡量之金融資產</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:FinancialAssetsAtAmortisedCost" contextRef="From20230101To20231231" escape="true">

同時符合下列兩條件之金融資產，按攤銷後成本衡量，並以應收票據、應收帳款、按攤銷後成本衡量之金融資產及其他應收款等項目列報於
資產負債表：

A.管理金融資產之經營模式：持有金融資產以收取合約現金流量
B.金融資產之合約現金流量特性：現金流量完全為支付本金及流通在外本金金額之利息

此等金融資產(不包括涉及避險關係者)後續以攤銷後成本【原始認列時衡量之金額，減除已償付之本金，加計或減除該原始金額與到期金額
間差額之累積攤銷數（使用有效利息法），並調整備抵損失】衡量。於除列、透過攤銷程序或認列減損利益或損失時，將其利益或損失認列
於損益。

以有效利息法(以有效利率乘以金融資產總帳面金額)或下列情況計算之利息，則認列於損益：

A.如屬購入或創始之信用減損金融資產，以信用調整後有效利率乘以金融資產攤銷後成本
B.非屬前者，惟後續變成信用減損者，以有效利率乘以金融資產攤銷後成本



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 金融資產減損</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ImpairmentOfFinancialAssets" contextRef="From20230101To20231231" escape="true">

本集團對按攤銷後成本衡量之金融資產，係以預期信用損失認列並衡量備抵損失。

本集團以反映下列各項之方式衡量預期信用損失：

A.藉由評估各可能結果而決定之不偏且以機率加權之金額
B.貨幣時間價值
C.與過去事項、現時狀況及未來經濟狀況預測有關之合理且可佐證之資訊(於資產負債表日無須過度成本或投入即可取得者)

衡量備抵損失之方法說明如下：

A.按12個月預期信用損失金額衡量：包括金融資產自原始認列後信用風險未顯著增加，或於資產負債表日判定為信用風險低者。此外，亦包
　括前一報導期間按存續期間預期信用損失金額衡量備抵損失，但於本期資產負債表日不再符合自原始認列後信用風險已顯著增加之條件者
　。
B.存續期間預期信用損失金額衡量：包括金融資產自原始認列後信用風險已顯著增加，或屬購入或創始之信用減損金融資產。
C.對於屬國際財務報導準則第15號範圍內之交易所產生之應收帳款或合約資產，本集團採用存續期間預期信用損失金額衡量備抵損失。

本集團於每一資產負債表日，以比較金融工具於資產負債表日與原始認列日之違約風險之變動，評估金融工具於原始認列後之信用風險是否
已顯著增加。另與信用風險相關資訊請詳附註十二。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 金融資產之除列</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:DerecognitionOfFinancialAssets" contextRef="From20230101To20231231" escape="true">

本集團持有之金融資產於符合下列情況之一時除列：

A.來自金融資產現金流量之合約權利終止。
B.已移轉金融資產且將該資產所有權之幾乎所有風險及報酬移轉予他人。
C.既未移轉亦未保留資產所有權之幾乎所有風險及報酬，但已移轉對資產之控制。

一金融資產整體除列時，其帳面金額與已收取或可收取對價加計認列於其他綜合損益之任何累計利益或損失總和間之差額係認列於損益。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　 金融負債及權益工具</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:FinancialLiabilitiesAndEquityInstruments" contextRef="From20230101To20231231" escape="true">

權益工具

權益工具係指表彰本集團於資產減除所有負債後剩餘權益之任何合約，本集團發行之權益工具係以取得之價款扣除直接發行成本後之金額認
列。

複合工具

本集團對所發行之可轉換公司債依其合約條款確認金融負債及權益組成要素。另對所發行之轉換公司債，係於區分權益要素前評估嵌入之買
、賣權之經濟特性及風險是否與主債務商品緊密關聯。

不涉及衍生工具之負債部分，其公允價值使用性質相當且不具轉換特性債券之市場利率評估，於轉換或贖回清償前，此部分金額分類為以攤
銷後成本衡量之金融負債；至於其他與主契約經濟特性風險不緊密關聯之嵌入式衍生工具部分(例如嵌入之買回權及贖回權經確認其執行價
格無法幾乎等於債務商品於每一執行日之攤銷後成本)，除屬權益組成要素外，分類為負債組成要素，並於後續期間以透過損益按公允價值
衡量；權益要素之金額則以轉換公司債公允價值減除負債組成部分決定之，其帳面金額於後續之會計期間不予重新衡量。若所發行之轉換公
司債不具權益要素，則依國際財務報導準則第9號混合工具之方式處理。

交易成本依照原始認列可轉換公司債分攤予負債及權益組成部分之比例，分攤至負債及權益組成部分。 

轉換公司債持有人於該轉換公司債到期前要求行使轉換權利時，先將負債組成要素之帳面金額調整至轉換當時應有之帳面金額，作為發行普
通股之入帳基礎。

金融負債

符合國際財務報導準則第9號適用範圍之金融負債於原始認列時，分類為透過損益按公允價值衡量之金融負債或以攤銷後成本衡量之金融負
債。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 負債或權益之分類</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ClassificationOfFinancialLiabilitiesAndEquityInstruments" contextRef="From20230101To20231231" escape="true">

本集團發行之負債及權益工具係依據合約協議之實質與金融負債及權益工具之定義分類為金融負債或權益。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 透過損益按公允價值衡量之金融負債</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:FinancialLiabilitiesAtFairValueThroughProfitOrLoss" contextRef="From20230101To20231231" escape="true">

透過損益按公允價值衡量之金融負債，包括持有供交易之金融負債及指定透過損益按公允價值衡量之金融負債。

當符合下列條件之一，分類為持有供交易：

A.其取得之主要目的為短期內出售；
B.於原始認列時即屬合併管理之可辨認金融工具組合之一部分，且有近期該組合為短期獲利之操作型態之證據；或
C.屬衍生工具(財務保證合約或被指定且有效之避險工具之衍生工具除外)。

對於包含一個或多個嵌入式衍生工具之合約，可指定整體混合(結合)合約為透過損益按公允價值衡量之金融負債；當符合下列因素之一而可
提供更攸關之資訊時，於原始認列時指定為透過損益按公允價值衡量：

A.該指定可消除或重大減少衡量或認列不一致；或
B.一組金融負債或ㄧ組金融資產及金融負債，依書面之風險管理或投資策略，以公允價值基礎管理並評估其績效，且合併公司內部提供予管
　理階層之該投資組合資訊，亦以公允價值為基礎。

此類金融負債再衡量產生之利益或損失認列為損益，該認列為損益之利益或損失包含該金融負債所支付之任何利息。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 按攤銷後成本衡量之金融負債</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:FinancialLiabilitiesAtAmortisedCost" contextRef="From20230101To20231231" escape="true">

以攤銷後成本衡量之金融負債包括應付款項及借款等，於原始認列後，續後以有效利率法衡量。當金融負債除列及透過有效利率法攤提時，
將其相關損益及攤銷數認列於損益。

攤銷後成本之計算考量取得時之折價或溢價及交易成本。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 金融負債之除列</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:DerecognitionOfFinancialLiabilities" contextRef="From20230101To20231231" escape="true">

當金融負債之義務解除、取消或失效時，則除列該金融負債。

當本集團與債權人間就具重大差異條款之債務工具進行交換，或對現有金融負債之全部或部分條款作重大修改(不論是否因財務困難)，以除
列原始負債並認列新負債之方式處理，除列金融負債時，將其帳面金額與所支付或應支付對價總額(包括移轉之非現金資產或承擔之負債)間
之差額認列於損益。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 金融資產及負債之互抵</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:OffsettingFinancialAssetsAndFinancialLiabilities" contextRef="From20230101To20231231" escape="true">

金融資產及金融負債僅於已認列金額目前具互抵之法律行使權利且有意圖以淨額交割或同時變現資產及清償負債時，方能予以互抵並以淨額
列示於資產負債表。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　 衍生金融工具及避險會計</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:DerivativeInstrumentsAndHedgeAccounting" contextRef="From20230101To20231231" escape="true">

本集團所持有或發行之衍生工具係用以規避匯率風險及利率風險，其中屬指定且為有效避險者，於資產負債表列報為避險之金融資產或負債
；其餘非屬指定且為有效避險者，則於資產負債表列報為透過損益按公允價值衡量之金融資產或金融負債。

衍生工具之原始認列係以衍生工具合約簽訂日之公允價值衡量，並於續後採公允價值衡量。當衍生工具之公允價值為正數時，為金融資產；
公允價值為負數時，則為金融負債。衍生工具公允價值變動直接認列於損益，惟涉及避險且屬有效部分者，則依避險類型認列於損益或權益
項下。

主契約為非金融資產或金融負債者，當嵌入於主契約之衍生工具，其經濟特性及風險與主契約並非緊密關聯，且主契約非屬透過損益按公允
價值衡量時，該嵌入式衍生工具應視為獨立之衍生工具處理。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 存貨</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Inventories" contextRef="From20230101To20231231" escape="true">

存貨按逐項比較之成本與淨變現價值孰低法評價。

成本指為使存貨達到可供銷售或可供生產狀態及地點所產生之成本：

原　　物　　料－以實際進貨成本，成本之計算採用加權平均法。
製成品及在製品－包括直接原料、人工及以正常產能分攤之固定製造費用，但不包含借款成本。成本之計算採用加權平均法。

淨變現價值指在正常情況下，估計售價減除至完工尚須投入之成本及銷售費用後之餘額。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 不動產（、廠房）及設備</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:PropertyPlantAndEquipment" contextRef="From20230101To20231231" escape="true">

不動產、廠房及設備係以取得成本為認列基礎，並減除累計折舊及累計減損後列示，前述成本包含不動產、廠房及設備之拆卸、移除及復原
其所在地點之成本及因未完工程所產生之必要利息支出。不動產、廠房及設備之各項組成若屬重大，則單獨提列折舊。當不動產、廠房及設
備之重大組成項目須被定期重置，本集團將該項目視為個別資產並以特定耐用年限及折舊方法分別認列。該等被重置部分之帳面金額，則依
國際會計準則第16號「不動產、廠房及設備」之除列規定予以除列。重大檢修成本若符合認列條件，係視為替換成本而認列為廠房及設備帳
面金額之一部分，其他修理及維護支出則認列至損益。

折舊係以直線法按下列資產之估計耐用年限計提：

房屋及建築　　　　　　　　 3∼50年
機器設備　　　　　　　　　 2∼25年
運輸設備　　　　　　　　　 5∼13年
辦公設備　　　　　　　　　 2∼17年
租賃改良　　　　　　　　　 2∼25年
其他設備　　　　　　　　　 2∼19年

不動產、廠房及設備之項目或任一重要組成部分於原始認列後，若予處分或預期未來不會因使用或處分而有經濟效益之流入，則予以除列並
認列損益。

不動產、廠房及設備之殘值、耐用年限及折舊方法係於每一財務年度終了時評估，若預期值與先前之估計不同時，該變動視為會計估計值變
動。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 投資性不動產</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:InvestmentProperty" contextRef="From20230101To20231231" escape="true">

本集團自有之投資性不動產係以原始成本衡量，並包含取得該項資產之交易成本。投資性不動產之帳面金額包括於達到成本可認列之條件下
，因修繕或新增現有投資性不動產而投入之成本，但一般日常發生之維修費用則不作為其成本之一部分。於原始認列後，除依國際財務報導
準則第5號「待出售非流動資產及停業單位」符合分類為待出售(或包括於分類為待出售之處分群組中)之條件者外，投資性不動產之衡量係
採成本模式，依國際會計準則第16號「不動產、廠房及設備」對該模式之規定處理，惟若其由承租人以使用權資產所持有且依國際財務報導
準則第5號之規定非為待出售者，係依國際財務報導準則第16號之規定處理。

折舊係以直線法按下列資產之估計耐用年限計提：

建築物　　　　　　　　　　　　30年

投資性不動產在處分、或永久不再使用且預期無法由處分產生未來經濟效益之情況下，即予以除列並認列損益。

本集團依資產實際用途決定轉入或轉出投資性不動產。

當不動產符合或不再符合投資性不動產定義且有證據顯示用途改變時，本集團將不動產轉列為投資性不動產或從投資性不動產轉出。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 租賃</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Leasing" contextRef="From20230101To20231231" escape="true">

本集團就合約成立日評估該合約是否係屬(或包含)租賃。若合約轉讓對已辨認資產之使用之控制權一段時間以換得對價，該合約係屬(或包
含)租賃。為評估合約是否轉讓對已辨認資產之使用之控制權一段時間，本集團評估在整個使用期間是否具有下列兩者：

(1) 取得來自使用已辨認資產之幾乎所有經濟效益之權利；及
(2) 主導已辨認資產之使用之權利。

對於合約係屬(或包含)租賃者，本集團將合約中每一租賃組成部分作為單獨租賃，並與合約中之非租賃組成部分分別處理。對於合約包含一
項租賃組成部分以及一項或多項之額外租賃或非租賃組成部分者，本集團以每一租賃組成部分之相對單獨價格及非租賃組成部分之彙總單獨
價格為基礎，將合約中之對價分攤至該租賃組成部分。租賃及非租賃組成部分之相對單獨價格，以出租人(或類似供應者)分別對該組成部分
(或類似組成部分)收取之價格為基礎決定。若可觀察之單獨價格並非隨時可得，本集團最大化可觀察資訊之使用以估計該單獨價格。

集團為承租人

除符合並選擇短期租賃或低價值標的資產之租賃外，當本集團係租賃合約之承租人時，對所有租賃認列使用權資產及租賃負債。

本集團於開始日，按於該日尚未支付之租賃給付之現值衡量租賃負債。若租賃隱含利率容易確定，租賃給付使用該利率折現。若該利率並非
容易確定，使用承租人增額借款利率。於開始日，計入租賃負債之租賃給付，包括與租賃期間內之標的資產使用權有關且於該日尚未支付之
下列給付：

(1) 固定給付(包括實質固定給付)，減除可收取之任何租賃誘因；
(2) 取決於某項指數或費率之變動租賃給付(採用開始日之指數或費率原始衡量)；
(3) 殘值保證下承租人預期支付之金額；
(4) 購買選擇權之行使價格，若本集團可合理確定將行使該選擇權；及
(5) 租賃終止所須支付之罰款，若租賃期間反映承租人將行使租賃終止之選擇權。

開始日後，本集團按攤銷後成本基礎衡量租賃負債，以有效利率法增加租賃負債帳面金額，反映租賃負債之利息；租賃給付之支付減少租賃
負債帳面金額。

本集團於開始日，按成本衡量使用權資產，使用權資產之成本包含：

(1) 租賃負債之原始衡量金額；
(2) 於開始日或之前支付之任何租賃給付，減除收取之任何租賃誘因；
(3) 承租人發生之任何原始直接成本；及
(4) 承租人拆卸、移除標的資產及復原其所在地點，或將標的資產復原至租賃之條款及條件中所要求之狀態之估計成本。

使用權資產後續衡量以成本減除累計折舊及累計減損損失後列示，亦即適用成本模式衡量使用權資產。

若租賃期間屆滿時標的資產所有權移轉予本集團，或若使用權資產之成本反映本集團將行使購買選擇權，則自開始日起至標的資產耐用年限
屆滿時，對使用權資產提列折舊。否則，本集團自開始日起至使用權資產之耐用年限屆滿時或租賃期間屆滿時兩者之較早者，對使用權資產
提列折舊。

本集團適用國際會計準則第36號「資產減損」判定使用權資產是否發生減損並處理任何已辨認之減損損失。

除符合並選擇短期租賃或低價值標的資產之租賃外，本集團於資產負債表列報使用權資產及租賃負債，並於綜合損益表分別列報與租賃相關
之折舊費用及利息費用。

本集團對短期租賃及低價值標的資產之租賃，選擇按直線基礎或另一種有系統之基礎，將有關該等租賃之租賃給付於租賃期間認列為費用。

對符合新型冠狀病毒肺炎大流行之直接結果而發生之相關租金減讓，本集團選擇不評估其是否係租賃修改，而將該租金減讓以租賃給付變動
處理，並已將該實務權宜作法適用於所有符合條件之租金減讓。

集團為出租人

本集團於合約成立日將其每一租賃分類為營業租賃或融資租賃。租賃如移轉附屬於標的資產所有權之幾乎所有風險與報酬，係分類為融資租
賃；若未移轉，則分類為營業租賃。於開始日，本集團於資產負債表認列融資租賃下所持有之資產，並按租賃投資淨額將其表達為應收融資
租賃款。

對於合約包含租賃組成部分以及非租賃組成部分，本集團適用國際財務報導準則第15號規定分攤合約中之對價。

本集團按直線基礎或另一種有系統之基礎，將來自營業租賃之租賃給付認列為租金收入。對於營業租賃之非取決於某項指數或費率之變動租
賃給付，於發生時認列為租金收入。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 無形資產</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:IntangibleAssets" contextRef="From20230101To20231231" escape="true">

單獨取得之無形資產於原始認列時係以成本衡量。透過企業合併取得之無形資產成本為收購日之公允價值。無形資產於原始認列後，係以其
成本減除累計攤銷及累計減損損失後之金額作為帳面金額。不符合認列條件之內部產生無形資產不予資本化，而係於發生時認列至損益。

無形資產之耐用年限區分為有限及非確定耐用年限。

有限耐用年限之無形資產係於其耐用年限內攤銷，並於存有減損跡象時進行減損測試。有限耐用年限之無形資產攤銷期間及攤銷方法係至少
於每一財務年度結束時進行複核。若資產之預估耐用年限與先前之估計不同或未來經濟效益消耗之預期型態已發生改變，則攤銷方法或攤銷
期間將予以調整並視為會計估計變動。

非確定耐用年限之無形資產不予攤銷，但於每一年度依個別資產或現金產生單位層級進行減損測試。非確定耐用年限之無形資產係於每期評
估是否有事件及情況繼續支持該資產之耐用年限仍屬非確定。若耐用年限由非確定改為有限耐用年限時，則推延適用。

無形資產之除列所產生之利益或損失係認列至損益。

發展中之無形資產－研究發展成本

研究成本發生時係認列為費用。若個別專案之發展階段支出符合下列條件，認列為無形資產：

(1) 該發展中之無形資產已達技術可行性，並將可供使用或出售。
(2) 有意圖完成該資產且有能力使用或出售該資產。
(3) 該資產將產生未來經濟效益。
(4) 具充足之資源以完成該資產。
(5) 發展階段之支出能可靠衡量。

資本化之發展支出於原始認列後，係採成本模式衡量；亦即以成本減除累計攤銷及累計減損後之金額作為帳面金額。此資產於發展階段期間
，每年進行減損測試，並自完成發展且達可供使用狀態時，於預期未來效益之期間內攤銷。

本集團無形資產會計政策資訊彙總如下：

　　類　　別　　　　　　　　　耐用年限　　　　　　　　　　　　　攤銷方法
————————　　　————————————　　　————————————————
　商標權　　　　　　　　有限耐用年限10年　　　　　　　估計經濟效益年限以直線法攤銷
　專利權　　　　　　　　有限耐用年限9∼20年　　　　　 估計經濟效益年限以直線法攤銷
　使用權/經銷權　　　　 有限耐用年限5∼13年　　　　　 估計經濟效益年限以直線法攤銷
　電腦軟體成本　　　　　有限耐用年限1∼7年　　　　　　估計經濟效益年限以直線法攤銷
　藥　證　　　　　　　　有限耐用年限2∼16年　　　　　 估計經濟效益年限以直線法攤銷
　客戶關係　　　　　　　有限耐用年限12年　　　　　　　估計經濟效益年限以直線法攤銷
　其　他　　　　　　　　有效耐用年限2∼10年　　　　　 估計經濟效益年限以直線法攤銷


</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 非金融資產減損</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ImpairmentOfNonFinancialAsset" contextRef="From20230101To20231231" escape="true">

本集團於每一報導期間結束日評估所有適用國際會計準則第36號「資產減損」之資產是否存有減損跡象。如有減損跡象或須針對某一資產每
年定期進行減損測試，本集團即以個別資產或資產所屬之現金產生單位進行測試。減損測試結果如資產或資產所屬現金產生單位之帳面金額
大於其可回收金額，則認列減損損失。可回收金額為淨公允價值或使用價值之較高者。

本集團於每一報導期間結束日針對商譽以外之資產，評估是否有跡象顯示先前已認列之減損損失可能已不存在或減少。如存有此等跡象，本
集團即估計該資產或現金產生單位之可回收金額。若可回收金額因資產之估計服務潛能變動而增加時，則迴轉減損。惟迴轉後帳面金額不超
過資產在未認列減損損失情況下，減除應提列折舊或攤銷後之帳面金額。

商譽所屬之現金產生單位或群組，不論有無減損跡象，係每年定期進行減損測試。減損測試結果如須認列減損損失，則先行減除商譽，減除
不足之數再依帳面金額之相對比例分攤至商譽以外之其他資產。商譽之減損，一經認列，嗣後不得以任何理由迴轉。

繼續營業單位之減損損失及迴轉數係認列於損益。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 負債準備</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Provisions" contextRef="From20230101To20231231" escape="true">

負債準備之認列條件係因過去事件所產生之現時義務(法定義務或推定義務)，於清償義務時，很有可能需要流出具經濟效益之資源，且該義
務金額能可靠估計。當本集團預期某些或所有負債準備可被歸墊時，只有當歸墊幾乎完全確定時認列為單獨資產。若貨幣時間價值影響重大
時，負債準備以可適當反映負債特定風險之現時稅前利率折現。負債折現時，因時間經過而增加之負債金額，認列為借款成本。

虧損性合約之負債準備

本集團依歷史經驗及其他已知原因估計虧損性合約之負債準備。

員工福利負債準備

本集團於報導期間結束日因員工已累積未使用之福利。

除役、復原及修復成本之負債準備

拆卸、移除不動產、廠房及設備及復原其所在地點所產生之除役負債準備，其金額以預期清償義務之現金流量估計折現值衡量，且將該除役
成本認列為資產成本之一部分。現金流量以反映除役負債特定風險之現時稅前利率折現。負債準備之折現攤銷於發生時認列為借款成本。估
計之未來除役成本於每個報導期間結束日進行適當之評估及調整。未來除役成本之估計值變動或折現率之改變，相對增加或減少相關資產成
本。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 庫藏股票</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:TreasuryStock" contextRef="From20230101To20231231" escape="true">

本集團於取得母公司股票(庫藏股票)時係以取得成本認列並作為權益之減項。庫藏股票交易之價差認列於權益項下。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 收入之認列</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:RevenueRecognition" contextRef="From20230101To20231231" escape="true">

本集團與客戶合約之收入主要包括銷售商品及CDMO－勞務收入及代工收入，會計處理分別說明如下：

銷售商品

本集團製造、經銷及銷售商品，承諾之商品於出貨時客戶即取得其控制(即客戶主導該商品之使用並取得該商品之幾乎所有剩餘效益之能力)
時認列收入，主要商品為西藥及保健品，本集團以合約敘明之價格為基礎認列收入，並減除估計之數量折扣或銷貨折讓之淨額認列金額。本
集團以累積經驗並採期望值估計數量折扣及銷貨折讓產生之變動對價，惟其範圍僅限於與變動對價相關之不確定性於後續消除時，所認列之
累計收入金額高度很有可能不會發生重大迴轉之部分。在協議之特定期間，對預期之數量折扣及銷貨折讓亦相對認列退款負債。

本集團銷售商品之授信期間為30∼180天，大部分合約於商品移轉控制且具有無條件收取對價之權利時，即認列應收帳款，該等應收帳款通
常期間短且不具重大財務組成部分；然有部分合約，由於簽約時即先向客戶收取部分對價，本集團承擔須於續後提供商品之義務，故認列為
合約負債。

本集團前述合約負債轉列收入之期間通常不超過一年，並未導致重大財務組成部分之產生。

CDMO－勞務收入

本集團提供生技藥品委託測試開發等相關服務。勞務收入於服務提供予客戶之財務報導期間內認列為收入。固定價格合約之收入係以資產負
債表日止已實際提供之服務占全部應提供服務之比例認列，服務之完工比例以實際發生之成本占估計總成本為基礎決定。客戶依照所協議之
付款時間表支付合約價款，當本集團已提供之服務超過客戶應付款時認列合約資產，若客戶應付款超過本集團已提供之服務時則認列為合約
負債。

本集團對收入、成本及完工程度之估計隨情況改變進行修正。任何導因於估計變動之估計收入、成本增加或減少，於導致修正之情況被管理
階層所知悉之期間內反映於損益。

CDMO－代工收入

本集團提供西藥委託製造之服務，主要係依相關協議內容代工，及合約敘明之價格為基礎認列收入，承諾之商品出貨時客戶即取得其控制(
即客戶主導該商品之使用並取得該商品之幾乎所有剩餘效益之能力)時認列收入。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 借款成本</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:BorrowingCost" contextRef="From20230101To20231231" escape="true">

直接可歸屬於取得、建造或生產符合要件之資產的借款成本，予以資本化為該資產成本之一部分。其他所有借款成本則認列為發生期間之費
用。借款成本係包括與舉借資金有關而發生之利息及其他成本。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 員工福利</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:EmployeeBenefits" contextRef="From20230101To20231231" escape="true">

退職後福利計畫

本公司及國內子公司員工退休辦法適用於所有正式任用之員工，員工退休基金全數提存於勞工退休準備金監督委員會管理，並存入退休基金
專戶，由於上述退休金係以退休準備金監督委員會名義存入，與本公司及國內子公司完全分離，故未列入上開合併財務報表中。國外子公司
員工退休辦法係依當地法令規定辦理。

對於屬確定提撥計畫之退職後福利計畫，國外子公司則依當地特定比例提撥並認列為當期費用。

對於屬確定福利計畫之退職後福利計畫，依據預計單位福利法於年度報導期間結束日按精算報告提列。淨確定福利負債(資產)再衡量數包括
計畫資產報酬與資產上限影響數之任何變動，並減除包含於淨確定福利負債(資產)淨利息之金額，以及精算損益。淨確定福利負債(資產)再
衡量數於發生時，列入其他綜合損益項下，並立即認列於其他權益。前期服務成本為計畫修正或縮減所產生之確定福利義務現值之變動數，
且於下列兩者較早之日期認列為費用：

(1) 當計畫修正或縮減發生時；及
(2) 當集團認列相關重組成本或離職福利時。

淨確定福利負債(資產)淨利息係由淨確定福利負債(資產)乘以折現率決定，兩者均於年度報導期間開始時決定，再考量該期間淨確定福利負
債(資產)因提撥金及福利支付產生之任何變動。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 股份基礎給付</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ShareBasedPayment" contextRef="From20230101To20231231" escape="true">

本集團與員工間權益交割之股份基礎給付交易，其成本係以權益工具之給與日公允價值衡量。公允價值係以適當之定價模式衡量。

權益交割之股份基礎給付交易之成本係於服務條件及績效條件達成之期間內逐期認列，並相對認列權益之增加。於既得日前每一報導期間結
束日針對權益交割交易所認列之累計費用，係反映既得期間之經過及本集團對最終將既得之權益工具數量之最佳估計。每一報導期間期初及
期末針對股份基礎給付交易所認列之累計成本變動數，則認列至該期間之損益。

股份基礎給付獎酬最終若未符合既得條件，則無須認列任何費用。但權益交割交易之既得條件如係與市價條件或非既得條件有關，則在所有
服務或績效條件均已達成之情況下，無論市價條件或非既得條件是否達成，相關費用仍予以認列。

於修改權益交割交易條件時，則至少認列未修改下之原始給付成本。股份基礎交易之交易條件修改若增加股份基礎給付交易之公允價值總數
或對員工有利時，則認列額外之權益交割交易成本。

權益交割之股份基礎給付獎酬計畫若被取消，則視為於取消日即已既得，並立即認列尚未認列之剩餘股份基礎給付費用，此包括企業或員工
可控制之非既得條件並未達成之獎酬計畫。若原先取消之獎酬係由新的獎酬計畫取代且於給與日即被確認將取代被取消之獎酬計畫，則將取
消及新給與之獎酬計畫視同原始獎酬計畫之修改。

流通在外選擇權之稀釋效果將於計算稀釋每股盈餘時，以額外股份計算其稀釋效果。

發行限制員工權利股票時，係以給與日所給與之權益商品公允價值為基礎，於既得期間認列薪資費用及相對之權益增加；於給與日時本集團
認列員工未賺得酬勞，員工未賺得酬勞屬過渡科目，於合併資產負債表中作為權益減項，並依時間經過轉列薪資費用。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 所得稅</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:IncomeTax" contextRef="From20230101To20231231" escape="true">

所得稅費用(利益)係指包含於決定本期損益中，與當期所得稅及遞延所得稅有關之彙總數。

當期所得稅

與本期及前期有關之本期所得稅負債(資產)，係以報導期間結束日已立法或實質性立法之稅率及稅法衡量。當期所得稅與認列於其他綜合損
益或直接認列於權益之項目有關者，係分別認列於其他綜合損益或權益而非損益。

未分配盈餘加徵營利事業所得稅部分，於股東會決議分配盈餘之日列為所得稅費用。

遞延所得稅

遞延所得稅係就報導期間結束日，資產與負債之課稅基礎與其於資產負債表之帳面金額間所產生之暫時性差異予以計算。

除下列兩者外，所有應課稅暫時性差異皆予認列為遞延所得稅負債：

(1) 商譽之原始認列；或非屬企業合併交易所產生之資產或負債原始認列，於交易當時既不影響會計利潤亦不影響課稅所得(損失)，且於交
　　易當時並未產生相應之應課稅及可減除暫時性差異。
(2) 因投資子公司、關聯企業及聯合協議權益所產生，其迴轉時點可控制且於可預見之未來很有可能不會迴轉之應課稅暫時性差異。

除下列兩者外，可減除暫時性差異、未使用課稅損失及未使用所得稅抵減產生之遞延所得稅資產，於很有可能有未來課稅所得之範圍內認列
：

(1) 與非屬企業合併交易之資產或負債原始認列所產生之可減除暫時性差異有關，於交易當時既不影響會計利潤亦不影響課稅所得(損失)，
　　且於交易當時並未產生相等之應課稅及可減除暫時性差異。
(2) 與投資子公司、關聯企業及聯合協議權益所產生之可減除暫時性差異有關，僅於可預見之未來很有可能迴轉且迴轉當時有足夠之課稅所
　　得以供該暫時性差異使用之範圍內認列。

遞延所得稅資產及負債係以預期資產實現或負債清償當期之稅率衡量，該稅率並以報導期間結束日已立法或實質性立法之稅率及稅法為基礎
。遞延所得稅資產及負債之衡量係反映報導期間結束日預期回收資產或清償負債帳面金額之方式所產生之租稅後果。遞延所得稅與不列於損
益之項目有關者，亦不認列於損益，而係依其相關交易認列於其他綜合損益或直接認列於權益。遞延所得稅資產於每一報導期間結束日予以
重新檢視並認列。

遞延所得稅資產與負債僅於本期所得稅資產及本期所得稅負債之互抵具有法定執行權，且遞延所得稅係屬同一納稅主體並與由同一稅捐機關
課徵之所得稅有關時，可予互抵。

依「國際租稅變革－支柱二規則範本(國際會計準則第12號之修正)」暫時性例外之規定，依此不得認列支柱二所得稅之遞延所得稅資產及負
債亦不得揭露其相關資訊。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 企業合併</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:BusinessCombination" contextRef="From20230101To20231231" escape="true">

企業合併係採用收購法進行會計處理。企業合併之移轉對價、所取得之可辨認資產及承擔之負債，係以收購日之公允價值衡量。收購者針對
每一企業合併，係以公允價值或被收購者可辨認淨資產之相對比例衡量非控制權益。所發生之收購相關成本係當期費用化並包括於管理費用
。

本集團收購業務時，係依據收購日所存在之合約條件、經濟情況及其他相關情況，進行資產與負債分類與指定是否適當之評估，包括被收購
者所持有主契約中嵌入式衍生金融工具之分離考量。

企業合併如係分階段完成者，則收購者先前所持有被收購者之權益，係以收購日之公允價值重新衡量，並將所產生之利益或損失認列為當期
損益。

收購者預計移轉之或有對價將以收購日之公允價值認列。被視為資產或負債之或有對價，其續後之公允價值變動將依國際財務報導準則第9
號規定認列為當期損益或其他綜合損益之變動。惟或有對價如係分類為權益時，則在其最終於權益項下結清前，均不予以重新衡量。

商譽之原始衡量係所移轉之對價加計非控制權益後之總數，超過本集團所取得可辨認資產與負債公允價值之金額；此對價如低於所取得淨資
產公允價值，其差額則認列為當期損益。

反向收購時，係由會計上被收購者發行其股份予會計上之收購者之股東。因此，會計上收購者未取得會計上被收購者權益而支付之移轉對價
之收購日公允價值，應基於為使法律上母公司之股東擁有反向收購後產生之合併後個體相同比率之權益、法律上子公司假使需發行權益之數
量。依前述方法所計算權益數量之公允價值，可作為交換被收購者之移轉對價公允價值。

反向併購之合併財務報表應反映法律上子公司按合併前帳面金額認列與衡量其資產及負債，並認列其依企業合併前保留盈餘之帳面金額。法
律上母公司則按公平價值認列與衡量其資產及負債。合併財務報表之股東權益總額等於法律上子公司合併前之股東權益總額加計對被收購者
之併購對價。



</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td colspan="2">　 其他</td>
					</tr>
					<tr>
						<td style="text-align:center">項目</td>
						<td style="text-align:center">說明</td>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:Others">
						<td><pre class="note"><ix:nonNumeric name="tifrs-notes:Item" contextRef="From20230101To20231231" escape="true">公允價值衡量</ix:nonNumeric></pre></td>
						<td><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true">　
公允價值係指於衡量日，市場參與者間在有秩序之交易中出售某一資產所能收取或移轉某一負債所需支付之價格。公允價值衡量假設該出售
資產或移轉負債之交易發生於下列市場之一：

(1) 該資產或負債之主要市場，或
(2) 若無主要市場，該資產或負債之最有利市場

主要或最有利市場必須是集團所能進入以進行交易者。

資產或負債之公允價值衡量係使用市場參與者於定價資產或負債時會使用之假設，其假設該等市場參與者依其經濟最佳利益為之。

非金融資產之公允價值衡量考量市場參與者藉由將該資產用於其最高及最佳使用或藉由將該資產出售予會將該資產用於其最高及最佳使用之
另一市場參與者，以產生經濟效益之能力。

本集團採用在相關情況下適合且有足夠資料可得之評價技術以衡量公允價值，並最大化攸關可觀察輸入值之使用且最小化不可觀察輸入值之
使用。

　</ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr>
				</table>
			</div>
			<br />
			<div id="SourcesOfUncertaintyFromSignificantAccountingJudgmentsAssumptionsAndEstimations">
				<table style="width:90%">
					<tr>
						<th colspan='5' style="text-align:left">重大會計判斷、假設及估計不確性之主要來源</th>
					</tr> 
					<tr>
						<td>　 重大會計判斷、假設及估計不確性之主要來源</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:SourcesOfUncertaintyFromSignificantAccountingJudgmentsAssumptionsAndEstimations" contextRef="From20230101To20231231" escape="true">

本集團編製合併財務報表時，管理階層須於報導期間結束日進行判斷、估計及假設，此將影響收入、費用、資產與負債報導金額及或有負債
之揭露。然而，這些重大假設與估計之不確定性可能導致資產或負債之帳面金額須於未來期間進行重大調整之結果。

1.判斷

　在採用本集團會計政策之過程中，管理階層進行下列對合併財務報表金額認列最具有重大影響之判斷：

　(1) 收入認列

　　　本集團就部分代工及經銷合約需履行之義務，需綜合考量本集團是否為該交易之主理人、承擔存貨風險或具有直接訂定價格之自由等
　　　因素，以決定本集團是否為主理人，故主理人或代理人之判斷將影響本集團收入認列金額。

　(2) 營業租賃承諾－集團為出租人

　　　本集團對投資性不動產組合已簽訂商業不動產租約。基於對其約定條款之評估，本集團仍保留這些不動產所有權之重大風險及報酬，
　　　並將該等租約以營業租賃處理。

　(3) 反向併購

　　　本集團將原持有之保瑞聯邦(股)公司全數股權以股份轉換方式取得晨暉生物科技(股)公司21,257仟股(持股比例約35.79%)，並取得對
　　　晨暉生物科技(股)公司及其子公司之控制力，因晨暉生物科技(股)公司與保瑞聯邦(股)公司於上開換股交易前非屬共同控制下之個體
　　　，並依國際財務報導準則規定，晨暉生物科技(股)公司與保瑞聯邦(股)公司於判斷收購者時，應與晨暉生物科技(股)公司之母公司作
　　　成一致之判斷，故將上開換股交易視為反向收購，保瑞聯邦(股)公司為會計上之收購者，晨暉生物科技(股)公司為會計上被收購者。

2.估計及假設

　於報導期間結束日對有關未來所作之估計及假設不確定性之主要來源資訊，具有導致資產及負債帳面金額於下一財務年度重大調整之重大
　風險。茲說明如下：

　(1) 存貨

　　　存貨淨變現價值之估計值係考量存貨發生毀損、全部或部分過時或售價下跌等情況，以估計時可得之存貨預期變現金額之最可靠證據
　　　為之，請詳附註六。

　(2) 收入認列－銷貨退回及折讓

　　　本集團依歷史經驗及其他已知原因估計銷貨退回及折讓，並於商品銷售時作為營業收入之減項，前述銷貨退回及折讓之估計，係於重
　　　大迴轉所認列之累計收入金額高度很有可能不會發生之前提為基礎，請詳附註六。

　(3) 所得稅

　　　所得稅的不確定性存在於對複雜稅務法規之解釋、產生未來課稅所得的金額及時點。由於廣泛的國際商業關係與契約的長期性和複雜
　　　性，其實際結果與所作假設間產生之差異，或此等假設於未來之改變，可能迫使將已入帳的所得稅利益和費用於未來予以調整。對所
　　　得稅之提列，係依據本集團營業所在各國之稅捐機關可能的查核結果，所作之合理估計。所提列的金額是基於不同因素，例如：以往
　　　稅務查核經驗及課稅主體與所屬稅捐機關對稅務法規解釋之不同。此解釋之差異，因集團個別企業所在地之情況，而可能產生各種議
　　　題。

　　　未使用之課稅損失與所得稅抵減遞轉後期及可減除暫時性差異，係於未來很有可能產生課稅所得或有應課稅暫時性差異之範圍內，認
　　　列遞延所得稅資產。決定遞延所得稅資產可認列之金額係以未來課稅所得及應課稅暫時性差異可能發生之時點及水準併同未來之稅務
　　　規劃策略為估計之依據。

　(4) 應收款項－減損損失之估計

　　　本集團應收款項減損損失之估計係採用存續期間預計信用損失金額衡量，將依據合約可收取之合約現金流量(帳面金額)與預期收取之
　　　現金流量(評估前瞻資訊)兩者間差額之現值為信用損失，惟短期應收款之折現影響不重大，信用損失以未折現之差額衡量。若未來實
　　　際現金流量少於預期，可能會產生重大減損損失，請詳附註六。

　(5) 股份基礎給付交易

　　　本集團與員工間之權益交割交易成本，係以給與日之權益工具公允價值衡量。估計股份基礎給付交易之公允價值時，應依給與條款決
　　　定最佳之定價模式。此估計亦要求決定定價模式所使用之最佳參數，包括：認股權的預期存續期間、預期波動率、預期股利率，以及
　　　對其所作之假設。對用於衡量股份基礎給付交易公允價值所使用的假設及模式，請詳附註六之說明。

　(6) 退職後福利計畫

　　　退職後福利計畫之確定福利成本與確定福利義務現值係取決於精算評價。精算評價牽涉各種不同假設，包括：折現率及預期薪資之增
　　　減變動等。

　(7) 非金融資產之減損

　　　當資產或現金產生單位之帳面金額大於其可回收金額時，即發生減損。可回收金額係指公允價值減處分成本與使用價值，二者孰高者
　　　。公允價值減處分成本之計算，是依據於衡量日，市場參與者間在有秩序之交易中出售資產所能收取或移轉負債所需支付之價格，經
　　　減除直接可歸屬於處分資產或現金產生單位之增額成本後之金額。使用價值是基於現金流量折現模式之計算。現金流量之預估係依據
　　　未來五年之預算，且不含本集團尚未承諾之重組，或為加強該被測試現金產生單位資產績效所需之未來重大投資。可回收金額容易受
　　　到現金流量折現模式所使用的折現率及基於外推目的所使用之預期未來現金流入與成長率之影響。用以決定不同現金產生單位可回收
　　　金額之主要假設，包括敏感度分析，請詳附註六之說明。

　(8) 企業合併商譽之衡量 

　　　本集團因企業合併於收購日取得資產負債公允價值之評估及商譽金額之決定，係以專家報告為基礎，涉及多項財務模型假設、參數設
　　　定及相關會計估計，可能會重大影響應認列之商譽金額，請參閱附註六。

　(9) 或有對價之公允價值衡量

　　　因企業合併所產生的或有事項，係於收購日時以公允價值評價，以作為企業合併之一部分。當或有事項符合衍生金融工具之定義時即
　　　屬金融負債，並於續後之每一報導期間結束日以公允價值重新衡量。公允價值之決定係基於現金流量之折現。關鍵假設則考慮達成每
　　　一績效指標之可能性及折現因子。



</ix:nonNumeric></pre></td>
					</tr>
				</table>
			</div>

			<br />
			<div id="TradeAndOtherReceivables"></div>
			<div class="title">應收款項</div>
			<div class="rptidx">單位：新臺幣仟元</div>
				<table style="width:90%">
					<tr>
						<th colspan='6' rowspan='1' style="text-align:left">明細表</th>
					</tr>
					<tr>
						<th colspan='6' rowspan='1' style="text-align:center">項目及金額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">項目</th>
						<th colspan='2' rowspan='1' style="text-align:center">金額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">本期</th>
						<th colspan='1' rowspan='1' style="text-align:center">去年同期</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:FinancialStatementAccountAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount2" contextRef="AsOf20231231" escape="true">應收票據－因營業而發生(總帳面金額)</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">54,323</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">36,900</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:FinancialStatementAccountAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount2" contextRef="AsOf20231231" escape="true">減：備抵損失</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:FinancialStatementAccountAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount2" contextRef="AsOf20231231" escape="true">應收票據－關係人(總帳面金額)</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:FinancialStatementAccountAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount2" contextRef="AsOf20231231" escape="true">減：備抵損失</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:FinancialStatementAccountAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount2" contextRef="AsOf20231231" escape="true">應收帳款(總帳面金額)</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,907,992</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,038,657</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:FinancialStatementAccountAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount2" contextRef="AsOf20231231" escape="true">減：備抵損失</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">17,408</ix:nonFraction>)</pre></td>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">10,314</ix:nonFraction>)</pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:FinancialStatementAccountAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount2" contextRef="AsOf20231231" escape="true">應收帳款－關係人(總帳面金額)</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">68,290</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">19,707</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:FinancialStatementAccountAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount2" contextRef="AsOf20231231" escape="true">減：備抵損失</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<th style="text-align:left" colspan='1'>合計</th>
						<td colspan='1' style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalTradeAndOtherReceivables" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,013,197</ix:nonFraction> </pre></td>
						<td colspan='3' style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalTradeAndOtherReceivables" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,084,950</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left" colspan='1'>說明</th>
						<td colspan='4' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ScheduleOfTradeAndOtherReceivables" contextRef="AsOf20231231" escape="true">本集團之應收票據皆屬未逾期，且未有提供擔保之情況。

本集團依國際財務報導準則第9號規定評估減損，備抵損失相關資訊，請詳附註六.24，信用風險相關資訊請詳附註十二。

本集團之應收帳款未有提供擔保之情況。

本集團對客戶之授信期間通常為30天至180天。於民國一一二年及一一一年十二月三十一日之總帳面金額，分別為3,976,282仟元
及6,058,364仟元，於民國一一二年及一一一年一月一日至十二月三十一日備抵損失相關資訊詳附註六.24，信用風險相關資訊請
詳附註十二。</ix:nonNumeric></pre></td>
					</tr>
				</table>
				<br />
				<table style="width:90%">
					<tr>
						<th colspan='6' rowspan='1' style="text-align:left">應收款項之帳齡分析</th>
					</tr>
					<tr>
						<th colspan='6' rowspan='1' style="text-align:center">帳齡區間及金額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">帳齡區間</th>
						<th colspan='2' rowspan='1' style="text-align:center">金額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">本期</th>
						<th colspan='1' rowspan='1' style="text-align:center">去年同期</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:AgeDistributionAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:AgeDistribution" contextRef="AsOf20231231" escape="true">未逾期</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,927,203</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,548,881</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:AgeDistributionAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:AgeDistribution" contextRef="AsOf20231231" escape="true">30天內</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">73,112</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">273,619</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:AgeDistributionAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:AgeDistribution" contextRef="AsOf20231231" escape="true">31天至60天</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,182</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">188,280</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:AgeDistributionAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:AgeDistribution" contextRef="AsOf20231231" escape="true">61天至90天</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,651</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">35,676</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:AgeDistributionAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:AgeDistribution" contextRef="AsOf20231231" escape="true">91天至120天</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">197</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,182</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:AgeDistributionAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:AgeDistribution" contextRef="AsOf20231231" escape="true">121天以上</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">852</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">37,312</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<th style="text-align:left" colspan='1'>合計</th>
						<td colspan='1' style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalPastDueButNotImpaired" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,013,197</ix:nonFraction> </pre></td>
						<td colspan='3' style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalPastDueButNotImpaired" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,084,950</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left" colspan='1'>說明</th>
						<td colspan='4' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:AgingAnalysisOfReceivablesThatArePastDueButNotImpaired2" contextRef="AsOf20231231" escape="true">註：本集團之應收票據皆屬未逾期。</ix:nonNumeric></pre></td>
					</tr>
				</table>
				<br /> 
				<table style="width:90%"> 
					<tr> 
						<th colspan='3' style="text-align:left">應收款項之備抵損失變動資訊</th> 
					</tr> 
					<tr> 
						<th></th> 
						<th colspan='1'>本期</th> 
						<th colspan='1'>去年同期</th> 
					</tr>
					<tr> 
						<th style="text-align:center"></th> 
						<th style="text-align:center">金額</th>
						<th style="text-align:center">金額</th>
					</tr> 
					<tr>
						<th style="text-align:left">　期初餘額</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance2" contextRef="AsOf20231231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">10,314</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance2" contextRef="AsOf20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,294</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　追溯適用IFRS 9影響數</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EffectOfRetrospectiveApplicationOfIFRS9" contextRef="From20230101To20231231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EffectOfRetrospectiveApplicationOfIFRS9" contextRef="From20220101To20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　提列減損損失</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ProvisionForImpairmentLoss" contextRef="From20230101To20231231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,547</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ProvisionForImpairmentLoss" contextRef="From20220101To20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,919</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　減損損失迴轉</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ReversalOfImpairmentLoss" contextRef="From20230101To20231231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ReversalOfImpairmentLoss" contextRef="From20220101To20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　因無法收回而沖銷之款項</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:WriteOffsChargedAgainstTheAllowanceAccounts" contextRef="From20230101To20231231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:WriteOffsChargedAgainstTheAllowanceAccounts" contextRef="From20220101To20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　折現轉回數</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ReversalOfDiscount" contextRef="From20230101To20231231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ReversalOfDiscount" contextRef="From20220101To20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　匯率影響數</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:CurrencyTranslationDifferences" contextRef="From20230101To20231231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">64</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:CurrencyTranslationDifferences" contextRef="From20220101To20221231_Total3" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">3</ix:nonFraction>)</pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　其他</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Others1" contextRef="From20230101To20231231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">483</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Others1" contextRef="From20220101To20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,104</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">　期末餘額</th>
					　<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance4" contextRef="AsOf20231231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">17,408</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance4" contextRef="AsOf20221231_Total3" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">10,314</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">說明</th>
						<td  colspan='2' style="text-align:left"></td>
					</tr>
				</table>
			<br />
			<div id="TransactionsBetweenRelatedParties"></div>
			<div class="title">關係人交易</div>
			<div class="rptidx">單位：新臺幣仟元</div>
			<br />
			<div style="text-align:center"> 母公司及最終控制者之名稱</div>
			<div style="text-align:center">無此情形／免揭露</div>
				<br />
				<table style="width:90%">
					<tr>
						<th colspan='2' rowspan='1' style="text-align:left">關係人名稱及關係</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">關係人名稱</th>
						<th colspan='1' rowspan='1' style="text-align:center">關係人關係</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NameAndRelatiohshipOfRelatedParty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfRelatedParty" contextRef="AsOf20231231" escape="true">和安行(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyRelationship" contextRef="AsOf20231231" escape="true">本集團實質關係人（註一）</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NameAndRelatiohshipOfRelatedParty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfRelatedParty" contextRef="AsOf20231231" escape="true">台員國際(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyRelationship" contextRef="AsOf20231231" escape="true">本集團實質關係人（註二）</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
					<th style="text-align:left" colspan='1'>說明</th> 
						<td colspan='3' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameAndRelatiohshipOfRelatedParty" contextRef="From20230101To20231231" escape="true">註一：和安行(股)公司於民國一一二年十一月後已非實質關係人，故僅列示與該公司民國一一二年十一月之前之交易。

註二：本集團於民國一一二年十一月一日完成對晨暉生物科技(股)公司之收購，並納入本集團合併報表編制主體，台員國際(股)公司因而成為
　　　本集團實質關係人，故僅列示與該公司民國一一二年十一月之後之交易。</ix:nonNumeric></pre></td> 
					</tr>
				</table>
			<br />
			<div class="title">與關係人間之重大交易事項</div>
			<div class="rptidx">單位：新臺幣仟元</div>
				<table style="width:90%">
					<tr>
						<th colspan='12' rowspan='1' style="text-align:left">營業收入</th>
					</tr>
					<tr>
						<th colspan='12' rowspan='1' style="text-align:center">關係人類別與金額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">帳列項目</th>
						<th colspan='1' rowspan='2' style="text-align:center">關係人類別/名稱</th>
						<th colspan='2' rowspan='1' style="text-align:center">金額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">本年度</th>
						<th colspan='1' rowspan='1' style="text-align:center">上年度</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:CategoriesOfRelatedPartiesAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccountForSignificantTransactionsBetweenRelatedParties" contextRef="From20230101To20231231" escape="true">銷貨</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CategoriesOfRelatedParties" contextRef="From20230101To20231231" escape="true">和安行(股)公司</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount8" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">34,779</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount8" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">35,419</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:CategoriesOfRelatedPartiesAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccountForSignificantTransactionsBetweenRelatedParties" contextRef="From20230101To20231231" escape="true">銷貨</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CategoriesOfRelatedParties" contextRef="From20230101To20231231" escape="true">台員國際(股)公司</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount8" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">40,740</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount8" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<th style="text-align:left" colspan='2'>合計</th>
						<td colspan='1' style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalOperationRevenue" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">75,519</ix:nonFraction> </pre></td>
						<td colspan='4' style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalOperationRevenue" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">35,419</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left" colspan='2'>說明</th>
						<td colspan='5' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:OperatingRevenue2" contextRef="From20230101To20231231" escape="true">本集團售予關係人之銷貨價格與非關係人相當，收款條件為月結60~120天，與一般交易相當。</ix:nonNumeric></pre></td>
					</tr>
				</table>
				<br />
				<table style="width:90%">
					<tr>
						<th colspan='6' rowspan='1' style="text-align:left">進貨</th>
					</tr>
					<tr>
						<th colspan='6' rowspan='1' style="text-align:center">關係人類別與金額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">關係人類別/名稱</th>
						<th colspan='2' rowspan='1' style="text-align:center">金額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">本年度</th>
						<th colspan='1' rowspan='1' style="text-align:center">上年度</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:CategoriesOfRelatedPartiesAndAmount2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CategoriesOfRelatedParties3" contextRef="From20230101To20231231" escape="true">和安行(股)公司</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount9" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">71,876</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount9" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">68,778</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<th style="text-align:left" colspan='1'>合計</th>
						<td colspan='1' style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalPurchasesOfGoods" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">71,876</ix:nonFraction> </pre></td>
						<td colspan='3' style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalPurchasesOfGoods" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">68,778</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left" colspan='1'>說明</th>
						<td colspan='4' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:PurchasesOfGoods" contextRef="From20230101To20231231" escape="true">本集團向關係人進貨價格係以成本加計必要之費用，進貨議價方式與非關係人相當，付款條件為月結120天。</ix:nonNumeric></pre></td>
					</tr>
				</table>
				<br />
				<table style="width:90%">
					<tr>
						<th colspan='12' rowspan='1' style="text-align:left">應收關係人款項</th>
					</tr>
					<tr>
						<th colspan='12' rowspan='1' style="text-align:center">帳列項目及關係人類別與金額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">帳列項目</th>
						<th colspan='1' rowspan='2' style="text-align:center">關係人類別/名稱</th>
						<th colspan='2' rowspan='1' style="text-align:center">金額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">本期</th>
						<th colspan='1' rowspan='1' style="text-align:center">去年同期</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:FinancialStatementAccountAndCategoriesOfRelatedPartiesAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount3" contextRef="AsOf20231231" escape="true">應收帳款－關係人</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CategoriesOfRelatedParties2" contextRef="AsOf20231231" escape="true">和安行(股)公司</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">19,707</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:FinancialStatementAccountAndCategoriesOfRelatedPartiesAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount3" contextRef="AsOf20231231" escape="true">應收帳款－關係人</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CategoriesOfRelatedParties2" contextRef="AsOf20231231" escape="true">台員國際(股)公司</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">68,290</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:FinancialStatementAccountAndCategoriesOfRelatedPartiesAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount3" contextRef="AsOf20231231" escape="true">應收帳款－關係人</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CategoriesOfRelatedParties2" contextRef="AsOf20231231" escape="true">減：備抵損失</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount3" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<th style="text-align:left" colspan='2'>合計</th>
						<td colspan='1' style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalAmountsReceivableFromRelatedParties" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">68,290</ix:nonFraction> </pre></td>
						<td colspan='4' style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalAmountsReceivableFromRelatedParties" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">19,707</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left" colspan='2'>說明</th>
						<td colspan='5' style="text-align:left"></td>
					</tr>
				</table>
				<br />
				<table style="width:90%">
					<tr>
						<th colspan='12' rowspan='1' style="text-align:left">應付關係人款項</th>
					</tr>
					<tr>
						<th colspan='12' rowspan='1' style="text-align:center">帳列項目及關係人類別與金額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">帳列項目</th>
						<th colspan='1' rowspan='2' style="text-align:center">關係人類別/名稱</th>
						<th colspan='2' rowspan='1' style="text-align:center">金額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">本期</th>
						<th colspan='1' rowspan='1' style="text-align:center">去年同期</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:FinancialStatementAccountAndCategoriesOfRelatedPartiesAndAmount2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount4" contextRef="AsOf20231231" escape="true">應付帳款－關係人</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CategoriesOfRelatedParties12" contextRef="AsOf20231231" escape="true">和安行(股)公司</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">25,031</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<th style="text-align:left" colspan='2'>合計</th>
						<td colspan='1' style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalAmountsPayableToRelatedParties" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td colspan='4' style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalAmountsPayableToRelatedParties" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">25,031</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left" colspan='2'>說明</th>
						<td colspan='5' style="text-align:left"></td>
					</tr>
				</table>
			<div style="text-align:center">預付款項</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">取得不動產、廠房及設備</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">處分不動產、廠房及設備</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">取得投資性不動產</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">處分投資性不動產</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">取得金融資產</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">處分金融資產</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">取得其他資產</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">處分其他資產</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">對關係人放款</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center"> 背書保證</div>
			<div style="text-align:center">無此情形／免揭露</div>
				<br />
				<table style="width:90%">
					<tr>
						<td style="width:120px"> 其它</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:OtherTransactionWithRelatedParties" contextRef="From20230101To20231231" escape="true">

推銷費用

　　　　　　　　　　　　　　　　　112年度　　　　　　 111年度
　　　　　　　　　　　　　　　———————　　　———————
和安行(股)公司　　　　　　　　　　 $12,925　　　　　　 $10,409
　　　　　　　　　　　　　　　＝＝＝＝＝＝＝　　　＝＝＝＝＝＝＝



</ix:nonNumeric></pre></td>
					</tr>
				</table>
			<div style="text-align:center">向關係人借款</div>
			<div style="text-align:center">無此情形／免揭露</div>
				<br />
				<table style="width:90%">
					<tr> 
						<th colspan='3' style="text-align:left">主要管理階層薪酬</th> 
					</tr> 
					<tr> 
						<th></th> 
						<th colspan='1'>本年度</th>
						<th colspan='1'>上年度</th>
					</tr>
					<tr>
						<th style="text-align:left">短期員工福利</th>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ShortTermEmployeeBenefits" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">85,307</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ShortTermEmployeeBenefits" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">37,190</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">退職後福利</th>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PostEmploymentBenefits" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">450</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PostEmploymentBenefits" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">238</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">其他長期員工福利</th>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:OtherLongTermBenefits" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:OtherLongTermBenefits" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">離職福利</th>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TerminationBenefits" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TerminationBenefits" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">股份基礎給付</th>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ShareBasedPayment2" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ShareBasedPayment2" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">合計</th>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalKeyManagementPersonnelCompensation" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">85,757</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalKeyManagementPersonnelCompensation" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">37,428</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">說明</th>
						<td  colspan='3' style="text-align:left"></td>
					</tr>
				</table>
			<br />
			<div id="LoansToOthers"></div>
			<div class="title">資金貸與他人</div>
			<div class="rptidx">單位：新臺幣仟元</div>
				<table style="width:90%">
					<tr>
						<th colspan='18' rowspan='1' style="text-align:left">資金貸與他人</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">編號</th>
						<th colspan='1' rowspan='2' style="text-align:center">貸出資金之公司</th>
						<th colspan='1' rowspan='2' style="text-align:center">貸與對象</th>
						<th colspan='1' rowspan='2' style="text-align:center">往來項目</th>
						<th colspan='1' rowspan='2' style="text-align:center">是否為關係人</th>
						<th colspan='1' rowspan='2' style="text-align:center">本期最高餘額</th>
						<th colspan='1' rowspan='2' style="text-align:center">期末餘額</th>
						<th colspan='1' rowspan='2' style="text-align:center">實際動支金額</th>
						<th colspan='1' rowspan='2' style="text-align:center">利率區間</th>
						<th colspan='1' rowspan='2' style="text-align:center">資金貸與性質</th>
						<th colspan='1' rowspan='2' style="text-align:center">業務往來金額</th>
						<th colspan='1' rowspan='2' style="text-align:center">有短期融通資金必要之原因</th>
						<th colspan='1' rowspan='2' style="text-align:center">提列備抵呆帳金額</th>
						<th colspan='2' rowspan='1' style="text-align:center">擔保品</th>
						<th colspan='1' rowspan='2' style="text-align:center">對個別對象資金貸與限額</th>
						<th colspan='1' rowspan='2' style="text-align:center">資金貸與總限額</th>
						<th colspan='1' rowspan='2' style="text-align:center">備註</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">名稱</th>
						<th colspan='1' rowspan='1' style="text-align:center">價值</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:LoansToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20230101To20231231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Lender1" contextRef="From20230101To20231231" escape="true">益邦製藥(股)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty1" contextRef="From20230101To20231231" escape="true">保瑞藥業(股)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementItem" contextRef="From20230101To20231231" escape="true">其他應收帳款-關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyTransaction" contextRef="From20230101To20231231" escape="true">是</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">400,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RangeOfInterestRates" contextRef="From20230101To20231231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NatureOfLoans" contextRef="From20230101To20231231" escape="true">(註4).2</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfSalesToPurchasesFromCounterparty" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:ReasonForShort-termLoans" contextRef="From20230101To20231231" escape="true">營業週轉</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AllowanceForBadDebts" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:Collateral">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Item1" contextRef="From20230101To20231231" escape="true">無</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Value" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfLoanAmountForIndividualCounterparty" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">927,959</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalLoanAmount1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,159,948</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:LoansToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20230101To20231231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Lender1" contextRef="From20230101To20231231" escape="true">益邦製藥(股)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty1" contextRef="From20230101To20231231" escape="true">景德製藥(股)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementItem" contextRef="From20230101To20231231" escape="true">其他應收帳款-關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyTransaction" contextRef="From20230101To20231231" escape="true">是</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">200,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RangeOfInterestRates" contextRef="From20230101To20231231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NatureOfLoans" contextRef="From20230101To20231231" escape="true">(註4).2</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfSalesToPurchasesFromCounterparty" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:ReasonForShort-termLoans" contextRef="From20230101To20231231" escape="true">營業週轉</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AllowanceForBadDebts" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:Collateral">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Item1" contextRef="From20230101To20231231" escape="true">無</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Value" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfLoanAmountForIndividualCounterparty" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">927,959</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalLoanAmount1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,159,948</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
					<th style="text-align:left" colspan='4'>母公司資金貸與他人餘額合計</th> 
						<td colspan='21' style="text-align:left"><pre><ix:nonFraction name="tifrs-notes:TotalEndingBalance1-Parent" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
					</tr>
					<tr>
					<th style="text-align:left" colspan='4'>子公司資金貸與他人餘額合計</th> 
						<td colspan='21' style="text-align:left"><pre><ix:nonFraction name="tifrs-notes:TotalEndingBalance1-Subsidiaries" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
					</tr>
					<tr>
					<th style="text-align:left" colspan='4'>母公司資金貸與他人實際動支金額合計</th> 
						<td colspan='21' style="text-align:left"><pre><ix:nonFraction name="tifrs-notes:TotalActualAmountProvided1-Parent" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
					</tr>
					<tr>
					<th style="text-align:left" colspan='4'>子公司資金貸與他人實際動支金額合計</th> 
						<td colspan='21' style="text-align:left"><pre><ix:nonFraction name="tifrs-notes:TotalActualAmountProvided1-Subsidiaries" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
					</tr>
					<tr>
					<th style="text-align:left" colspan='4'>備註</th> 
						<td colspan='21' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Note-LoansToOthers" contextRef="From20230101To20231231" escape="true">(註1) 本公司及子公司資金融通資訊應於編號欄註明，編號之填寫方法如下：
　　　(1) 發行人填0。
　　　(2) 被投資公司按公司別由阿拉伯數字1開始依序編號。
(註2) 對個別對象之資金融通限額：
　　　(1) 有業務往來者：個別貸與金額以不超過最近期財務報表股權淨值百分之十且不超過雙方前一年度業務往來交易總額為限。
　　　　　所稱交易總額係指雙方間進貨或銷貨金額孰高者。
　　　(2) 有資金融通之必要者：個別貸與金額以不超過最近期財務報表股權淨值百分之四十為限。
(註3) 資金貸與總額額度
　　　(1) 本公司對外資金貸與總額不得超過最近期財務報表股權淨值百分之五十為限。
　　　(2) 子公司對外資金貸與總額不得超過最近期財務報表股權淨值百分之五十為限。
(註4) 資金貸與性質之填寫方法如下：
　　　(1) 有業務往來者請填1。
　　　(2) 有短期融通資金之必要者請填2。
(註5) 資金貸與性質屬1者，應填列業務往來金額，業務往來金額係指貸出資金之公司與貸與對象最近十二個月之業務往來金額。
(註6) 資金貸與性質屬2者，應具體說明必要貸與資金之原因及貸與對象之資金用途，例如償還借款、購置設備、營業週轉…等。</ix:nonNumeric></pre></td> 
					</tr>
				</table>
			<br />
			<div id="EndorsementGuaranteeProvidedToOthers"></div>
			<div class="title">為他人背書保證</div>
			<div class="rptidx">單位：新臺幣仟元</div>
				<table style="width:90%">
					<tr>
						<th colspan='15' rowspan='1' style="text-align:left">為他人背書保證</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">編號</th>
						<th colspan='1' rowspan='2' style="text-align:center">背書保證者公司名稱</th>
						<th colspan='2' rowspan='1' style="text-align:center">被背書保證對象</th>
						<th colspan='1' rowspan='2' style="text-align:center">對單一企業背書保證限額</th>
						<th colspan='1' rowspan='2' style="text-align:center">本期最高背書保證餘額</th>
						<th colspan='1' rowspan='2' style="text-align:center">期末背書保證餘額</th>
						<th colspan='1' rowspan='2' style="text-align:center">實際動支金額</th>
						<th colspan='1' rowspan='2' style="text-align:center">以財產擔保之背書保證金額</th>
						<th colspan='1' rowspan='2' style="text-align:center">累計背書保證金額佔最近期財務報表淨值之比率</th>
						<th colspan='1' rowspan='2' style="text-align:center">背書保證最高限額</th>
						<th colspan='1' rowspan='2' style="text-align:center">屬母公司對子公司背書保證</th>
						<th colspan='1' rowspan='2' style="text-align:center">屬子公司對母公司背書保證</th>
						<th colspan='1' rowspan='2' style="text-align:center">屬對大陸地區背書保證</th>
						<th colspan='1' rowspan='2' style="text-align:center">備註</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">公司名稱</th>
						<th colspan='1' rowspan='1' style="text-align:center">關係</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20230101To20231231" escape="true">保瑞藥業(股)公司</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20230101To20231231" escape="true">保瑞聯邦(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20230101To20231231" escape="true">(註二).2</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">45,423,935</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">25,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">45,423,935</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20230101To20231231" escape="true">Y</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20230101To20231231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20230101To20231231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20230101To20231231" escape="true">保瑞藥業(股)公司</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20230101To20231231" escape="true">益邦製藥(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20230101To20231231" escape="true">(註二).2</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">45,423,935</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">717,500</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">45,423,935</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20230101To20231231" escape="true">Y</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20230101To20231231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20230101To20231231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20230101To20231231" escape="true">保瑞藥業(股)公司</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20230101To20231231" escape="true">保瑞生技(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20230101To20231231" escape="true">(註二).2</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">45,423,935</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">360,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">240,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">2.64</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">45,423,935</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20230101To20231231" escape="true">Y</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20230101To20231231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20230101To20231231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20230101To20231231" escape="true">保瑞藥業(股)公司</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20230101To20231231" escape="true">安成國際藥業(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20230101To20231231" escape="true">(註二).2</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">45,423,935</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,050,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">45,423,935</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20230101To20231231" escape="true">Y</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20230101To20231231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20230101To20231231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20230101To20231231" escape="true">保瑞藥業(股)公司</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20230101To20231231" escape="true">BORA PHARMACEUTICAL SERVICES INC.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20230101To20231231" escape="true">(註二).2</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">45,423,935</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,868,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,784,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,784,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">30.64</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">45,423,935</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20230101To20231231" escape="true">Y</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20230101To20231231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20230101To20231231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20230101To20231231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20230101To20231231" escape="true">安成國際藥業(股)公司</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20230101To20231231" escape="true">景德製藥(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20230101To20231231" escape="true">(註二).4</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,049,453</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">200,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,623,632</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20230101To20231231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20230101To20231231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20230101To20231231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:EndorsementGuaranteeProvidedToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20230101To20231231" escape="true">2</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheEndorserGuarantor" contextRef="From20230101To20231231" escape="true">益邦製藥(股)公司</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:Counterparty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20230101To20231231" escape="true">景德製藥(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Relationship1" contextRef="From20230101To20231231" escape="true">(註二).4</ix:nonNumeric></pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOnEndorsementGuaranteeAmountProvidedToIndividualCounterparty" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,298,720</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">200,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">200,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">200,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfEndorsementsGuaranteesSecuredWithCollateral" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:RatioOfAccumulatedEndorsementGuaranteeAmountToNetAssetOfTheCompanyPerLatestFinancialStatements" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">8.62</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalGuaranteeEndorsementAmount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,198,970</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToSubsidiaryByParentCompany" contextRef="From20230101To20231231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToParentCompanyBySubsidiaries" contextRef="From20230101To20231231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:EndorsementsGuaranteesProvidedToCompanyInMainlandChina" contextRef="From20230101To20231231" escape="true">N</ix:nonNumeric></pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
					<th style="text-align:left" colspan='4'>母公司背書保證餘額合計</th> 
						<td colspan='18' style="text-align:left"><pre><ix:nonFraction name="tifrs-notes:TotalEndingBalance2-Parent" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,024,000</ix:nonFraction> </pre></td> 
					</tr>
					<tr>
					<th style="text-align:left" colspan='4'>子公司背書保證餘額合計</th> 
						<td colspan='18' style="text-align:left"><pre><ix:nonFraction name="tifrs-notes:TotalEndingBalance2-Subsidiaries" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">200,000</ix:nonFraction> </pre></td> 
					</tr>
					<tr>
					<th style="text-align:left" colspan='4'>母公司背書保證實際動支金額合計</th> 
						<td colspan='18' style="text-align:left"><pre><ix:nonFraction name="tifrs-notes:TotalActualAmountProvided2-Parent" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,784,000</ix:nonFraction> </pre></td> 
					</tr>
					<tr>
					<th style="text-align:left" colspan='4'>子公司背書保證實際動支金額合計</th> 
						<td colspan='18' style="text-align:left"><pre><ix:nonFraction name="tifrs-notes:TotalActualAmountProvided2-Subsidiaries" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">200,000</ix:nonFraction> </pre></td> 
					</tr>
					<tr>
					<th style="text-align:left" colspan='4'>備註</th> 
						<td colspan='18' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Note-EndorsementGuaranteeProvidedToOthers" contextRef="From20230101To20231231" escape="true">註一：編號欄之說明如下：
　　　(1) 本公司填0。
　　　(2) 被投資公司依公司別由阿拉伯數字1開始依序編號，同一公司編碼應相同。
註二：背書保證者與被背書保證對象之關係有下列七種，標示種類即可：
　　　(1) 有業務往來之公司。
　　　(2) 公司直接及間接持有表決權之股份超過百分之五十之公司。
　　　(3) 直接及間接對公司持有表決權之股份超過百分之五十之公司。
　　　(4) 公司直接及間接持有表決權股份達百分之九十以上之公司間。
　　　(5) 基於承攬工程需要之同業間或共同起造人間依合約規定互保之公司。
　　　(6) 因共同投資關係由全體出資股東依其持股比率對其背書保證之公司。
　　　(7) 同業間依消費者保護法規範從事預售屋銷售合約之履約保證連帶擔保。
註三：對單一企業背書保證限額：本公司以不超過本公司淨值五倍為限；安成以不超過其淨值20%為限；益邦以不超過其淨值十倍為限。
註四：背書保證最高限額：本公司以不超過本公司淨值五倍為限；安成以不超過其淨值50%為限；益邦以不超過其淨值十倍為限。</ix:nonNumeric></pre></td> 
					</tr>
				</table>
			<br />
			<div id="SignificantIntercompanyTransactionsBetweenConsolidatedEntities"></div>
			<div class="title">母子公司間業務關係及重要交易往來情形</div>
			<div class="rptidx">單位：新臺幣仟元</div>
				<table style="width:90%">
					<tr>
						<th colspan='8' rowspan='1' style="text-align:left">母子公司間業務關係及重要交易往來情形</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">編號</th>
						<th colspan='1' rowspan='2' style="text-align:center">交易人名稱</th>
						<th colspan='1' rowspan='2' style="text-align:center">交易往來對象</th>
						<th colspan='1' rowspan='2' style="text-align:center">與交易人之關係</th>
						<th colspan='4' rowspan='1' style="text-align:center">交易往來情形</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">科目</th>
						<th colspan='1' rowspan='1' style="text-align:center">金額</th>
						<th colspan='1' rowspan='1' style="text-align:center">交易條件</th>
						<th colspan='1' rowspan='1' style="text-align:center">佔合併總營收或總資產之比率</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">保瑞藥業(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">益邦製藥(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">(註二).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">應收帳款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">64,309</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">發票日起算60天</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.26</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">保瑞藥業(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">益邦製藥(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">(註二).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">銷貨收入</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">259,891</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">發票日起算60天</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">1.83</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">保瑞藥業(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">BORA PHARMACEUTICAL SERVICES INC.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">(註二).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">其他應收款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">25,952</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">發票日起算60天</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.10</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">保瑞藥業(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">BORA PHARMACEUTICAL SERVICES INC.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">(註二).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">其他收入</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">44,394</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">發票日起算60天</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.31</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">保瑞藥業(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">安成國際藥業(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">(註二).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">其他應收款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">94,907</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">發票日起算60天</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.38</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">保瑞藥業(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">安成國際藥業(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">(註二).1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">其他收入</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">106,740</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">發票日起算60天</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.75</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">益邦製藥(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">安成國際藥業(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">(註二).3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">應收帳款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">60,072</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">發票日起算60天</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.24</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">益邦製藥(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">安成國際藥業(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">(註二).3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">銷貨收入</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">365,087</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">發票日起算60天</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">2.57</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">益邦製藥(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">保瑞聯邦(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">(註二).3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">銷貨收入</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">28,912</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">發票日起算60天</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.20</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">益邦製藥(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">TWi Pharmaceuticals USA, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">(註二).3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">銷貨收入</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">60,502</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">發票日起算60天</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.43</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">2</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">Bora Pharmaceuticals USA Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">BORA PHARMACEUTICAL SERVICES INC.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">(註二).3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">其他應收款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">28,740</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">月結30天</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.11</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">2</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">Bora Pharmaceuticals USA Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">BORA PHARMACEUTICAL SERVICES INC.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">(註二).3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">其他收入</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">110,105</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">月結30天</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.78</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">2</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">Bora Pharmaceuticals USA Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">TWi Pharmaceuticals USA, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">(註二).3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">其他收入</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">14,402</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">發票日起算60天</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.10</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">3</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">安成國際藥業(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">益邦製藥(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">(註二).3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">銷貨收入</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">14,881</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">發票日起算60天</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.10</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">3</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">安成國際藥業(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">TWi Pharmaceuticals USA, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">(註二).3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">應收帳款</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,603,451</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">發票日起算120天</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">14.38</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">3</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">安成國際藥業(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">TWi Pharmaceuticals USA, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">(註二).3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">銷貨收入</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,476,832</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">發票日起算120天</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">52.65</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">4</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">景德製藥(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">安成國際藥業(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">(註二).3</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">銷貨收入</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">14,899</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">發票日起算60天</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.10</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
					<th style="text-align:left" colspan='1'>備註</th> 
						<td colspan='11' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Note-SignificantIntercompanyTransactionsBetweenConsolidatedEntities" contextRef="From20230101To20231231" escape="true">註一：母公司及子公司相互間之業務往來資訊應分別於編號欄註明，編號之填寫方法如下：
　　　(1) 母公司填0。
　　　(2) 子公司依公司別由阿拉伯數字1開始依序編號。
註二：與交易人之關係有以下三種，標示種類即可：
　　　(1) 母公司對子公司。
　　　(2) 子公司對母公司。
　　　(3) 子公司對子公司。
註三：交易往來金額佔合併總營收或總資產比率之計算，若屬資產負債科目者，以期末餘額佔合併總資產之方式計算；若屬損益科目者，
　　　以期末累積金額佔合併總營收之方式計算。
註四：編製合併報表時業已沖銷。</ix:nonNumeric></pre></td> 
					</tr>
				</table>
			<br />
			<div id="NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence"></div>
			<div class="title">被投資公司名稱、所在地區…等相關資訊</div>
			<div class="rptidx">單位：新臺幣仟元；股數：股</div>
				<table style="width:90%">
					<tr>
						<th colspan='13' rowspan='1' style="text-align:left">被投資公司名稱、所在地區…等相關資訊</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">投資公司名稱</th>
						<th colspan='1' rowspan='2' style="text-align:center">被投資公司名稱</th>
						<th colspan='1' rowspan='2' style="text-align:center">地區別代號</th>
						<th colspan='1' rowspan='2' style="text-align:center">所在地區</th>
						<th colspan='1' rowspan='2' style="text-align:center">主要營業項目</th>
						<th colspan='2' rowspan='1' style="text-align:center">原始投資金額</th>
						<th colspan='3' rowspan='1' style="text-align:center">期末持股情形</th>
						<th colspan='1' rowspan='2' style="text-align:center">被投資公司本期損益</th>
						<th colspan='1' rowspan='2' style="text-align:center">本期認列之投資損益</th>
						<th colspan='1' rowspan='2' style="text-align:center">備註</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">本期期末</th>
						<th colspan='1' rowspan='1' style="text-align:center">去年年底</th>
						<th colspan='1' rowspan='1' style="text-align:center">股數</th>
						<th colspan='1' rowspan='1' style="text-align:center">比率</th>
						<th colspan='1' rowspan='1' style="text-align:center">帳面金額</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">本公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20230101To20231231" escape="true">聯邦化學製藥(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20230101To20231231" escape="true">台灣</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">西藥製造及批發</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">165,874</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">155</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">311</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20230101To20231231" escape="true">(註三)</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">本公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20230101To20231231" escape="true">保瑞聯邦(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20230101To20231231" escape="true">台灣</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">西藥批發及保健保養品批發</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">190,466</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">41,810</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">24,037</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20230101To20231231" escape="true">(註一)(註四)</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">本公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20230101To20231231" escape="true">益邦製藥(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20230101To20231231" escape="true">台灣</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">西藥製造及代工</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,156,810</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,156,810</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">165,000,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,270,850</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">540,128</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">540,128</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">本公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20230101To20231231" escape="true">Bora Pharmaceuticals USA Inc</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20230101To20231231" escape="true">211</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20230101To20231231" escape="true">美國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">西藥批發</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">59,969</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">59,969</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">500,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">70,098</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,889</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,889</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">本公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20230101To20231231" escape="true">BORA PHARMACEUTICAL SERVICES INC.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20230101To20231231" escape="true">29</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20230101To20231231" escape="true">加拿大</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">西藥製造及代工</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">219,279</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">219,279</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">100,000,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">50.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,418,525</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">630,101</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">315,051</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">本公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20230101To20231231" escape="true">保瑞管理顧問(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20230101To20231231" escape="true">台灣</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">管理顧問</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,000</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">100,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,389</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,458</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,458</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">本公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20230101To20231231" escape="true">保瑞生技(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20230101To20231231" escape="true">台灣</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">生物技術服務、研究發展服務業及西藥製造業</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,103,720</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,103,720</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">39,425,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">65.70</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,194,554</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">85,611</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">56,246</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">本公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20230101To20231231" escape="true">保豐生技(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20230101To20231231" escape="true">台灣</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">生物技術研究及管理顧問</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">100</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">100</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">10,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">41</ix:nonFraction>)</pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">72</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">72</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">本公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20230101To20231231" escape="true">安成國際藥業(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20230101To20231231" escape="true">台灣</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">西藥製造及批發</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,676,416</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,676,416</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">60,000,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,364,161</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,343,391</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,246,787</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20230101To20231231" escape="true">(註二)</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">本公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20230101To20231231" escape="true">晨暉生物科技(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20230101To20231231" escape="true">台灣</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">保健食品研發、製造及銷售</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,138,633</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">21,257,168</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">35.79</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,143,896</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">73,107</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,981</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20230101To20231231" escape="true">(註四)</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">益邦製藥(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20230101To20231231" escape="true">BORA PHARMACEUTICAL SERVICES INC.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20230101To20231231" escape="true">29</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20230101To20231231" escape="true">加拿大</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">西藥製造及代工</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">213,100</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">213,100</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">100,000,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">50.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,418,525</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">630,101</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">315,050</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">益邦製藥(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20230101To20231231" escape="true">景德製藥(股)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20230101To20231231" escape="true">台灣</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">西藥製造及代工</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">160,126</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">64,252,492</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">98.85</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">101,364</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">123,608</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">57,618</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20230101To20231231" escape="true">(註一)(註三)</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">安成國際藥業(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20230101To20231231" escape="true">景德製藥(股)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20230101To20231231" escape="true">台灣</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">西藥製造及代工</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">580,866</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">123,608</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">64,117</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20230101To20231231" escape="true">(註三)</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">安成國際藥業(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20230101To20231231" escape="true">TWI Pharmaceuticals USA, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20230101To20231231" escape="true">211</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20230101To20231231" escape="true">美國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">西藥批發</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">231,982</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">231,982</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">38</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">999,107</ix:nonFraction>)</pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">256,797</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">256,797</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">晨暉生物科技(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20230101To20231231" escape="true">Sunway Group Holding Limited</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20230101To20231231" escape="true">176</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20230101To20231231" escape="true">塞席爾</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">投資公司</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">18,947</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">18,947</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">1,000,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,788</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">2,076</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">672</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20230101To20231231" escape="true">(註四)</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">晨暉生物科技(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20230101To20231231" escape="true">宸潤行銷(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20230101To20231231" escape="true">台灣</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">保健食品批發零售</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,550</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,550</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">255,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">51.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,988</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">586</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">39</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20230101To20231231" escape="true">(註四)</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">晨暉生物科技(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20230101To20231231" escape="true">保瑞聯邦(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20230101To20231231" escape="true">台灣</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">西藥批發及保健保養品批發</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,141,932</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">22,618,880</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">332,497</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">41,810</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">14,447</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20230101To20231231" escape="true">(註四)</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">Sunway Group Holding Limited</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20230101To20231231" escape="true">Sunway Investment(H.K.) Limited</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20230101To20231231" escape="true">92</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20230101To20231231" escape="true">香港</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">投資公司</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">18,776</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">18,776</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">3,500,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,789</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">2,044</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">640</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20230101To20231231" escape="true">(註四)</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">保瑞聯邦(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20230101To20231231" escape="true">聯邦化學製藥(股)公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20230101To20231231" escape="true">台灣</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">西藥製造及批發</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">31,558</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">1,500,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">31,401</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">311</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">156</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20230101To20231231" escape="true">(註三)</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
					<th style="text-align:left" colspan='1'>備註</th> 
						<td colspan='18' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Note-NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence" contextRef="From20230101To20231231" escape="true">註一：係考量公司間逆流交易之已(未)實現損益之影響數。
註二：係考量收購日可辨認資產之公允價值與帳面金額差異所產生之折舊及攤銷影響數。
註三：於民國一一二年七月因集團組織重組，將子公司－安成國際藥業(股)公司持有之景德製藥(股)有限公司之98.64%股權轉售與子公司－益邦製藥(股)
　　　公司；另本公司原持有之聯邦化學製藥(股)公司之100%股權轉售與子公司－保瑞聯邦(股)公司，請參閱本公司民國一一二年度合併財務報表附註六
　　　。
註四：本公司於民國一一二年八月二十一日董事會決議通過以持有之保瑞聯邦(股)公司全數股權與晨暉生物科技(股)公司進行股份轉換，並取得晨暉生物
　　　科技(股)公司及其子公司之35.79%股權，並於民國一一二年十一月一日取得控制力納入本集團合併報表之編制主體中，故僅認列取得控制力後被投
　　　資公司之本期利益。</ix:nonNumeric></pre></td> 
					</tr>
				</table>
			<br />
			<div id="InvestmentInMainlandChina"></div>
			<div class="title">大陸地區投資</div>
			<div class="rptidx">單位：新臺幣仟元</div>
				<table style="width:90%">
					<tr>
						<th colspan='14' rowspan='1' style="text-align:left">轉投資大陸地區之事業相關資訊</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">大陸被投資公司名稱</th>
						<th colspan='1' rowspan='2' style="text-align:center">主要營業項目</th>
						<th colspan='1' rowspan='2' style="text-align:center">實收資本額</th>
						<th colspan='1' rowspan='2' style="text-align:center">投資方式</th>
						<th colspan='1' rowspan='2' style="text-align:center">本期期初自台灣匯出累積投資金額</th>
						<th colspan='2' rowspan='1' style="text-align:center">本期匯出或收回投資金額</th>
						<th colspan='1' rowspan='2' style="text-align:center">本期期末自台灣匯出累積投資金額</th>
						<th colspan='1' rowspan='2' style="text-align:center">被投資公司本期損益</th>
						<th colspan='1' rowspan='2' style="text-align:center">本公司直接或間接投資之持股比例</th>
						<th colspan='1' rowspan='2' style="text-align:center">本期認列投資損益</th>
						<th colspan='1' rowspan='2' style="text-align:center">期末投資帳面價值</th>
						<th colspan='1' rowspan='2' style="text-align:center">截至本期止已匯回台灣之投資收益</th>
						<th colspan='1' rowspan='2' style="text-align:center">備註</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">匯出</th>
						<th colspan='1' rowspan='1' style="text-align:center">收回</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:InformationOfInvestmentInMainlandChina">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvesteeInMainlandChina" contextRef="From20230101To20231231" escape="true">晨泰生物科技(東莞)有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">保健食品批發零售</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalAmountOfPaid-inCapital" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">17,654</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MethodOfInvestment" contextRef="From20230101To20231231" escape="true">2</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedOutflowOfInvestmentFromTaiwanAtTheBeginningOfThePeriod" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">17,654</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:InvestmentFlowsForThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Outflow" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Inflow" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedOutflowOfInvestmentFromTaiwanAtTheEndOfThePeriod" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">17,654</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,995</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnershipThroughDirectAndIndirectInvestmentByTheCompany" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized2" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,995</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValueAtTheEndOfThePeriod" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,178</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedInwardRemittanceOfEarningsAsOfTheEndOfThePeriod" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,725</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
					<th style="text-align:left" colspan='1'>備註</th> 
						<td colspan='17' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Note-InformationOfInvestmentInMainlandChina" contextRef="From20230101To20231231" escape="true">註一：投資方式區分為下列三種：
　　　(ㄧ)直接赴大陸地區從事投資
　　　(二)透過第三地區公司再投資大陸
　　　(三)其他方式
註二：經台灣母公司簽證會計師查核之財務報表認列。
註三：係依據民國97年8月29日經濟部經審字第09704604680號令規定以不超過晨暉生物科技(股)公司之淨值之百分之六十為限。</ix:nonNumeric></pre></td> 
					</tr>
				</table>
				<br />
				<table style="width:90%">
					<tr>
						<th colspan='4' rowspan='1' style="text-align:left">轉投資大陸地區限額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">公司名稱</th>
						<th colspan='1' rowspan='1' style="text-align:center">本期期末累計自台灣匯出赴大陸地區投資金額</th>
						<th colspan='1' rowspan='1' style="text-align:center">經濟部投審會核准投資金額</th>
						<th colspan='1' rowspan='1' style="text-align:center">依經濟部投審會規定赴大陸地區投資限額</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:LimitOnInvestmentInMainlandChina">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20230101To20231231" escape="true">晨暉生物科技股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedInvestmentInMainlandChinaAtTheEndOfThePeriod" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">17,654</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentAmountAuthorizedByTheInvestmentCommissionOfMOEA" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">19,547</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:UpperLimitOnInvestmentInMainlandChinaImposedByTheInvestmentCommissionOfMOEA" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,918,477</ix:nonFraction> </pre></td> 
						</ix:tuple>
					</tr>
					<tr>
					<th style="text-align:left" colspan='1'>備註</th> 
						<td colspan='5' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Note-LimitOnInvestmentInMainlandChina" contextRef="From20230101To20231231" escape="true">註：係依據民國97年8月29日經濟部經審字第09704604680號令規定以不超過晨暉生物科技(股)公司之淨值之百分之六十為限。</ix:nonNumeric></pre></td> 
					</tr>
				</table>
			<br />
			<div id="NonoperatingIncomeAndExpenses"></div>
			<div class="title">營業外收入及支出</div>
			<div class="rptidx">單位：新臺幣仟元</div>
			<br />
			<div id="NonoperatingIncomeAndExpenses"></div>
			<div style="text-align:center">利息收入</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<br />
				<table style="width:90%">
					<tr>
						<th style="text-align:left" colspan="4">　 其他收入</th>
					</tr>
					<tr>
						<th style="text-align:center">代號</th>
						<th style="text-align:center">會計項目</th>
						<th style="text-align:center">2023年1月1日至12月31日</th>
						<th style="text-align:center">2022年1月1日至12月31日</th>
					</tr>
					<tr>
						<td>N7190</td>
						<td>　　 其他收入－其他</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:OtherIncomeOthers_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">93,392</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:OtherIncomeOthers_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">30,684</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<td>N7010</td>
						<td>　　 其他收入合計</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:OtherIncome_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">93,392</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:OtherIncome_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">30,684</ix:nonFraction> </pre></td>
					</tr>
				</table>
			<br />
				<br /> 
				<table style="width:90%"> 
					<tr> 
						<th style="text-align:left" colspan="4">　 其他利益及損失</th> 
					</tr> 
					<tr> 
						<th style="text-align:center">代號</th> 
						<th style="text-align:center">會計項目</th> 
						<th style="text-align:center">2023年1月1日至12月31日</th> 
						<th style="text-align:center">2022年1月1日至12月31日</th> 
					</tr>					<tr>
						<td>N7210</td>
						<td>　　 處分不動產、廠房及設備利益(損失)</td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-notes:GainsLossesOnDisposalsOfPropertyPlantAndEquipment_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,997</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-notes:GainsLossesOnDisposalsOfPropertyPlantAndEquipment_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">2,357</ix:nonFraction>)</pre></td>
					</tr>
					<tr>
						<td>N7230</td>
						<td>　　 外幣兌換利益(損失)</td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-notes:ForeignExchangeGainsLosses_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">67,505</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:ForeignExchangeGainsLosses_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">47,923</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<td>N7235</td>
						<td>　　 透過損益按公允價值衡量之金融資產(負債)利益(損失)</td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-notes:GainsLossesOnFinancialAssetsOrLiabilitiesAtFairValueThroughProfitOrLoss_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,044,183</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-notes:GainsLossesOnFinancialAssetsOrLiabilitiesAtFairValueThroughProfitOrLoss_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">47,787</ix:nonFraction>)</pre></td>
					</tr>
					<tr>
						<td>N7600</td>
						<td>　　 其他利益及損失</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:OtherGainsAndLossesOthers_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,539</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-notes:OtherGainsAndLossesOthers_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,911</ix:nonFraction>)</pre></td>
					</tr>
					<tr>
						<td>N7020</td>
						<td>　　 其他利益及損失淨額</td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-notes:OtherGainsAndLosses_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,107,146</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-notes:OtherGainsAndLosses_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,132</ix:nonFraction>)</pre></td>
					</tr>
				</table>
			<br />
				<br /> 
				<table style="width:90%"> 
					<tr> 
						<th style="text-align:left" colspan="4">　 財務成本</th> 
					</tr> 
					<tr> 
						<th style="text-align:center">代號</th>
						<th style="text-align:center">會計項目</th> 
						<th style="text-align:center">2023年1月1日至12月31日</th> 
						<th style="text-align:center">2022年1月1日至12月31日</th> 
					</tr> 
					<tr>
						<td>N7510</td>
						<td>　　 利息費用</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:InterestExpense_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">171,239</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:InterestExpense_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">108,727</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<td>N7050</td>
						<td>　　 財務成本淨額</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:FinanceCosts_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">171,239</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:FinanceCosts_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">108,727</ix:nonFraction> </pre></td>
					</tr>
				</table>
			<br /> 
			</span>
		</div> 
		<br /> 
	</div> 
</body> 
</html> 

<!--This instance document is created by SIIAP V2.4.9-->

